<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>BioC-API</source><date>20250207</date><key>collection.key</key><document><id>PMC6017639</id><infon key="license">CC BY</infon><passage><infon key="article-id_doi">10.3390/molecules23040940</infon><infon key="article-id_pmc">PMC6017639</infon><infon key="article-id_pmid">29673237</infon><infon key="article-id_publisher-id">molecules-23-00940</infon><infon key="elocation-id">940</infon><infon key="issue">4</infon><infon key="kwd">antianxiety antidepression panax notoginseng saponins network pharmacology review</infon><infon key="license">Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).</infon><infon key="name_0">surname:Xie;given-names:Weijie</infon><infon key="name_1">surname:Meng;given-names:Xiangbao</infon><infon key="name_2">surname:Zhai;given-names:Yadong</infon><infon key="name_3">surname:Zhou;given-names:Ping</infon><infon key="name_4">surname:Ye;given-names:Tianyuan</infon><infon key="name_5">surname:Wang;given-names:Zhen</infon><infon key="name_6">surname:Sun;given-names:Guibo</infon><infon key="name_7">surname:Sun;given-names:Xiaobo</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">23</infon><infon key="year">2018</infon><offset>0</offset><text>Panax Notoginseng Saponins: A Review of Its Mechanisms of Antidepressant or Anxiolytic Effects and Network Analysis on Phytochemistry and Pharmacology</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>151</offset><text>Panax notoginseng (Burk) F. H. Chen, as traditional Chinese medicine, has a long history of high clinical value, such as anti-inflammatory, anti-oxidation, inhibition of platelet aggregation, regulation of blood glucose and blood pressure, inhibition of neuronal apoptosis, and neuronal protection, and its main ingredients are Panax notoginseng saponins (PNS). Currently, Panax notoginseng (Burk) F. H. Chen may improve mental function, have anti-insomnia and anti-depression effects, alleviate anxiety, and decrease neural network excitation. However, the underlying effects and the mechanisms of Panax notoginseng (Burk) F. H. Chen and its containing chemical constituents (PNS) on these depression-related or anxiety-related diseases has not been completely established. This review summarized the antidepressant or anxiolytic effects and mechanisms of PNS and analyzed network targets of antidepressant or anxiolytic actions with network pharmacology tools to provide directions and references for further pharmacological studies and new ideas for clinical treatment of nervous system diseases and drug studies and development. The review showed PNS and its components may exert these effects through regulating neurotransmitter mechanism (5-HT, DA, NE), modulation of the gamma-amino butyric acid (GABA) neurotransmission, glutamatergic system, hypo-thalamus-pituitary-adrenal (HPA) axis, brain-derived neurotrophic factor (BDNF), and its intracellular signaling pathways in the central nervous system; and produce neuronal protection by anti-inflammatory, anti-oxidation, or inhibition of neuronal apoptosis, or platelet aggregation and its intracellular signaling pathways. Network target analysis indicated PNS and its components also may have anti-inflammatory and anti-apoptotic effects, which leads to the preservation of brain nerves, and regulate the activity and secretion of nerve cells, exerting anti-depression and anxiolytic effects, which may provide new directions for further in-depth researches of related mechanisms.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>2192</offset><text>1. Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2208</offset><text>Depression is a chronic and recurrent syndrome of mood disorder with significant and lasting low mood. Clinical depressed patients are characteristic of its disproportionate, emotional depression, being not commensurate with their situation, low self-esteem, and even pessimism, including depressed mood from depression to grief. Some may have suicide attempts or behaviors; in severe cases, there may be hallucinations, delusions, and other psychotic symptoms. The pathogenesis and etiology of still remain unknown. However, today's knowledge proposes multiple neuronal and hormonal systems involved in the pathophysiology of the disease. Current evidence suggests that the occurrence of depression may be related to a reduced secretion of neurotransmitters, such as dopamine (DA), norepinephrine (NE), and serotonin (5-HT), neuronal apoptosis, inflammation, intestinal flora, and other factors. There are currently four classes of antidepressant drugs and atypical antidepressants. However, these drugs have undesirable side effects, with high relapse rates and a long onset of therapeutic action. Therefore, critically important is the development of efficient and safe drugs for the treatment of depression.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3422</offset><text>Panax notoginsen (Burk) F. H. Chen (Sanqi in Chinese) is a commonly used Chinese medicine, the root of which has been used for the treatment of hemoptysis, hemostatic, and hematoma in China and other Asian countries for its hemostatic and cardiovascular effects for more than several hundred years. To the best of our knowledge, over 200 chemical constituents have been isolated from Panax notoginseng (Burk) F. H. Chen, but the main ingredients are Panax notoginseng saponins (PNS), being classified into four types: protopanaxadiol, protopanaxatriol, ocotilloltype, and oleanolic acid constituents. There are others reported to be flavonoids, cyclopeptides, saccharides, and inorganic elements. Pharmacological studies have shown that notoginseng and its extracts have many functions, such as anti-inflammatory, anti-oxidation, inhibition of platelet aggregation, regulation of blood glucose and blood pressure, inhibition of neuronal apoptosis, and neuronal protection.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4395</offset><text>Recent studies have found that PNS have good preventive and therapeutic effects on neurological diseases of the brain, especially in antidepressant and anti-anxiety effects. The preliminary determination was that anti-depressant and anti-anxiety effects may occur by increasing the levels of the brain monoamine neurotransmitters 5-hydroxytryptamine (5-HT) and norepinephrine (NE) in the central nervous system. Experiments also have shown that PNS modulates Na+ currents and Ca2+ concentrations, and increases nestin and brain-derived neurotrophic factor (BDNF). Moreover, PNS or single compounds exerted antidepressant-like effects by regulating the release of interleukin (IL)-1beta, IL-6, and tumor necrosis factor (TNF)-alpha, or anti-inflammatory cytokines IL-4 and IL-10. Such breakthroughs have been made to determine there are antidepressant effects on estrogen in the human body. Estrogen can act on the PI3K/Akt, MAPK/ERK, mTORC1, and other signaling pathways, and then these pathways are regulated by growth factors that protect neurons and produce estrogen-like effects on synapses. However, the role of PNS or its single compounds in normal function and in disease remains to be not much elucidated. </text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5610</offset><text>Therefore, this review summarized the antidepressant or anxiolytic effects and mechanisms of PNS and analyzed network targets of antidepressant or anxiolytic actions with network pharmacology tools, to provide reference for further pharmacological studies and new ideas for clinical treatment of nervous system diseases and drug studies and development. </text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>5965</offset><text>2. Mechanisms of Antidepression</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>5997</offset><text>2.1. Panax Notoginseng Saponins</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>6029</offset><text>Modern pharmacological studies have found Panax notoginseng saponins (PNS) have good preventive and therapeutic effects of brain neurological diseases. Ginsenosides Rg1, Rb1, Re, and notoginsenoside R1, as the representative, showed anti-depressant and anti-anxiety activity. The evaluation methods of antidepressant effects include sucrose preference test (SPF), forced swimming test (FST), open field test (OFT), elevated plus-maze (EPM) test, and tail suspension test (TST). </text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>6508</offset><text>PNS (58.6%) significantly decreased immobility time in the forced swim test with little effect on locomotion in the chronic mild stress model, and significantly improved the level of animal activity and sucrose consumption, which may have antidepressant-like effects. Besides this, when PNS was digested by Snail Enzyme to 50%, it produced the best antidepressant effects, and the main active ingredient includes ginsenosides Rb1, Rb2, Rc, and Rb3. These were shown in Table 1. </text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>6987</offset><text>At present, the antidepressant mechanisms have been partly proved to be that PNS upregulates expression of brain-derived neurotrophic factor (BDNF) by regulating multiple upstream neural signal transduction pathways, including AC/cAMP/PKA and mitogen-activated protein kinase channels (TrKB/MAPK/PSK); meanwhile, PNS regulates calmodulin kinase channel (Ca2+/CaM/CaMK), reduces internal concentration of Ca2+ in nerve cells, and promotes the release of neurotransmitters 5-HT, NE, and DA. Thereby, PNS exerted its antidepressant-like effect. These are shown in Table 1.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>7557</offset><text>Besides this, both PNS and ginseng total saponin (GTS) have significant antidepressant effects on LPS-induced murine CD-1 mouse models by reducing mRNA levels for IL-1beta, IL-6, TNF-alpha, and indoleamine 2,3-dioxygenase (IDO) in hippocampus. These were shown in Table 1.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>7830</offset><text>2.2. Single Component: Rg1</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>7857</offset><text>Among Panax notoginseng saponins, ginsenoside Rg1, Rb1, Rc, and Rb3 are important representative components of PNS antidepressant, belonging to the original ginseng diol type saponins, and the contents of ginsenoside Rb3 and Rc were 17.66% and 9.32%, respectively.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>8122</offset><text>By conducting open field tests (OFT), tail suspension tests (TST), forced swimming tests (FST), or sugar consumption tests, ginsenoside Rg1 showed antidepressant effect in chronic mild stress (CMS)- or chronic unpredictable mild stress (CUMS)-induced animal models of Depression. Ginsenoside Rg1 significantly reversed increase of serum corticosterone induced by CMS, increased the phosphorylation of cAMP response element-binding protein (CREB) in rat cerebral amygdala induced by CUMS, up-regulated expression of BDNF in the hippocampus, and down-regulated serum corticosterone lever. It also regulates the hyperthyroidism of HPA axis in depression, plays a positive role in activating BDNF and protein kinase, and also improves the neuronal status, and increases the number of neurons and dendritic spine density, producing antidepressant effect. </text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>8973</offset><text>Moreover, ginsenoside Rg1 could up-regulate the expression of connexin, improve the gap junctional connectivity of astrocytes in the prefrontal cortex, decrease the permeability, increase the ultrastructure, and reduce the depression-like behavior of rats induced by CUMS. As present studies found that Ly6C (hi) blood mononuclear cells can be used as anti-depressant regulatory targets, Rg1 selectively suppressed Ly6C hi monocytes recruitment to the inflamed mice brain, Rg1 pretreatment on activated THP-1 monocytes retarded their ability to trigger CCL2 secretion from co-cultured U251 MG astrocytes, and CCL2-triggered p38/MAPK and PI3K/Akt activation were blocked by Rg1. Besides this, Rg1 suppressed depression-like behaviors in CUMS model rats by reducing contents of Glu and Asp in hippocampus and increasing GABA and Tau content, exerting antidepressant effects.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>9846</offset><text>2.3. Single Component: Rb1</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>9873</offset><text>Ginsenoside Rb1 and ginsenoside K, its metabolite, could activate 5-HT2AR, and may also up-regulate the mRNA expression of 5-HT2AR, which showed anti-depressant effects on ovariectomized rat model carried with ovariectomy, whereas the anti-depression effect of Rb1 and ginsenoside K may be reversed by the 5-HT2AR antagonist (ritanserin), which generally indicates that Rb1 has a similar-neurotransmitter of 5-HT activation effect. These were shown in Table 1.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>10334</offset><text>2.4. Single Component: Rb3</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>10361</offset><text>Ginsenoside Rb3 had significant anti-immobility effects in mice in the forced swim and tail suspension tests, and reduced the number of escape failures in the learned helplessness procedure by using the forced swimming test, tail suspension test, and learned helplessness procedure. Biochemical variations (i.e., brain-derived neurotrophic factor and the monoamine neurotransmitters 5-hydroxytryptamine, dopamine, and norepinephrine) are mainly involved in Rb3's antidepressant-like effects. Using GABAA receptor agonist muscimol was similar to that of ginsenoside Rb3, which indicated that the activation of the GABAA receptor is correlated with the neuroprotective mechanisms of ginsenoside Rb3. These were shown in Table 1.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>11090</offset><text>2.5. Single Component: Rg3</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>11117</offset><text>Ginsenoside Rg3 exerted a significant antidepressant effect on LPS-induced mouse model by immunomodulatory and anti-inflammatory effects, which decreased levels of IL-6, TNF-alpha in plasma and indoleamine-2,3-deoxygenates (IDO) expression in the hippocampus, reduced or inhibited the turnover of the tryptophan-serotonin (5-HT) in the hippocampus, regulated the secretory activity of microglia microglial cells and the transcription of NF-kappa-B in the nucleus, and repaired tryptophan-kynurenine metabolic balance, thereby weakening the depressant-like behavior or symptoms. In addition, Rg3 exerted an anti-depressant effect on chronic social defeat stress (CSDS)-induced mice model, but had no significant effect on animal activity and enhanced BNDF expression. These were shown in Table 1.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>11913</offset><text>Besides this, ginsenoside Rg5 induced antidepressant effect by inhibiting Trk and AchE activity and upregulating BDNF expression in chronic social defeat stress (CSDS)-induced model mice. Ginsenoside Re regulated the central adrenergic system, inhibited tyrosine hydroxylase (TH) expression in the locus coeruleus, blocked the decrease of BDNF in hippocampus, and regulated the secretion of corticosterone in the HPA axis, thus alleviating and regulating the synthesis of depression or anxiety symptoms. These were shown in Table 1.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>12446</offset><text>3. Mechanisms of Antianxiety</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>12475</offset><text>At present, representatives of Panax notoginseng (Burk) F. H. Chen, stem and leaf soap components or part of ginsenosides that have been shown to have anxiolytic effects are ginsenoside Rb1, Re, PPD, ginsenoside Rh1, and ginsenoside Rg3. In chronic mild stress (CMS)-induced rats, l-DOPA-induced running behavior in mice or 5-HTP-induced head-twitch tests, PNS decreased immobility time, increased the levels of 5-hydroxytryptamine, dopamine, and noradrenaline, reduced basal [Ca2+]i levels in cultured neurons, which were mediated by modulation of brain monoamine neurotransmitters and intracellular Ca2+ concentration, producing anti-anxiety and antidepressant effect. These are shown in Table 2.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>13174</offset><text>Ginsenoside Rb1 reduced the anxiety index, increased the risk assessment, reduced grooming behaviors in the EPM test, and increased the total number of line crossings of an open field in single prolonged stress (SPS)-induced model and in model rats of post-traumatic stress disorder (PTSD) by increasing the expression of neuropeptide Y induced by SPS-induced decrease in hypothalamic; increase the expression of tyrosine hydroxylase in locus coeruleus and decrease the mRNA expression of BDNF in hippocampus. </text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>13685</offset><text>At the same time, ginsenoside Rb1 and Re's intestinal metabolites PPD and K, ginsenoside Rh1 can increase arm opening time in EPM and reduce the serum levels of adrenone IL-6, and the role of gamma-aminobutyrate-A (GABA A) receptor(s) exert anxiolytic effects. Pseudoginsenoside-F(11) greatly ameliorated the anxiety-like behaviors induced by MA, shortened MA-induced prolonged latency, decreased the error counts, significant decreases in the contents of dopamine (DA), 3,4-dihydroxyphenacetic acid (DOPAC), homovanillic acid (HVA), and 5-hydroxyindoacetic acid (5-HIAA) in the brain of MA-treated mice; and partially, but significantly, a antagonize MA-induced decreases of DA. Besides, Ginsenoside Rg3, Rh2, Rg1 and Ro significantly increased both the frequency and duration of open arm entries, indicating that ginsenoside Rb1 is one of the active anxiolytic components. These were shown in Table 2.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>14589</offset><text>4. Network Target Analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>14616</offset><text>Based on reported researches of each component above, including ginsenoside Rg1, Rg3, Rg5, Rb1, Rb3, Re, Rh1, Rh2, Ro, pseudoginsenoside-F(11), ginsenoside K, and notoginsenoside R1, the structures and target properties of 12 active ingredients among them was obtained from the PubChem database (), shown as Table 3; then network targets of antidepressant, anxiolytic actions, or other pharmacological effects were analyzed with network pharmacology tools. In the present work, an integrated in silico approach was introduced to identify the target proteins for the active ingredients of Panax notoginseng (Burk) F. H. Chen (Table 3). Predictive models were used, including STITCH () and Swiss Target Prediction (), and databases were mined including Herbal Ingredients' Targets database (). Finally, targets related to antidepressant or anxiolytic effects and other effects were determined, interacting with the selected 12 active ingredients of Panax notoginseng (Burk) F. H. Chen (Table 4). </text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>15613</offset><text>Main predicted network targets of Panax notoginseng (Burk) F. H. Chen were shown in Table 4 and Figure 1. Twenty-six targets were identified for 12 active ingredients of Panax notoginseng (Burk) F. H. Chen with 87 interactions. The more link lines between compounds and predicted protein targets, the greater the linear density, indicating that they are more likely to interact, but specific experiments are needed to confirm. This is shown in Figure 1.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>16067</offset><text>Based on the scores (Table 4), multiple therapeutic targets concerning central nervous system were mediated by the active ingredients of Panax notoginseng (Burk) F. H. Chen, such as BAK1, BCL2, BCL2A1, JUN, MAPK8, AKT1, NFKB1, TP53, and APAF1. Most of these targets are mainly involved in apoptosis and inflammation of vascular and central neural systems. Figure 1 and Figure 2 show that BCL2-A1, BCL2, NF-kappa-B, and TP53 was predicted to have strong association actions of compound and predicted target network of Panax notoginseng (Burk) F. H. Chen, indicating that Notoginseng saponins may exert anti-depression and anti-anxiety effects through inflammatory regulation and anti-apoptotic pathway. </text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>16770</offset><text>BCL2 suppresses apoptosis in a variety of cell systems, including neural cells and factor-dependent lymphohematopoietic, and regulates cell death by controlling the mitochondrial membrane permeability by binding to the apoptosis-activating factor (APAF-1). NF-kappa-B is a pleiotropic transcription factor present in almost all cell types, and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes, such as inflammation, immunity, differentiation, cell growth, tumorigenesis, and apoptosis. TP53 acts as a tumor suppressor in many tumor types, and induces growth arrest or apoptosis depending on the physiological circumstances and cell type, involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. These indicate that PNS may have anti-inflammatory and anti-apoptotic effects, which leads to the preservation of brain nerves, and regulate the activity and secretion of nerve cells, exerting anti-depression and anxiolytic effects, which may provide new directions for further in-depth researches of related mechanisms.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>17980</offset><text>5. Conclusions</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>17995</offset><text>Depression is becoming the world's fourth-largest disease, and may become the second-largest disease in 2020, second only to cardiac disease. Antidepressants can be divided into four categories: tricyclic, tetracyclic, monoamine oxidase inhibitors, and other new antidepressants, and sometimes can cause addiction or undesirable side effects. Therefore, new drugs or treatment methods are required. Future studies should consider investigating alternatives to conventional drugs or Chinese medicinal plants. These have been used for more than a thousand years with generally carry a low risk of negative side effects. Panax notoginseng (Burk) F. H. Chen, as traditional Chinese medicine has a long history of high clinical value, such as anti-inflammatory, anti-oxidation, inhibition of platelet aggregation, regulation of blood glucose and blood pressure, inhibition of neuronal apoptosis, and neuronal protection. Currently, Panax notoginseng (Burk) F. H. Chen may improve mental function, have anti-insomnia and anti-depression effects, alleviate anxiety, and decrease neural network excitation.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>19096</offset><text>As outlined above, we have confirmed that PNS, ginsenoside Rg1, ginsenoside Rb1, ginsenosidenRg3, ginsenoside Rh2, ginsenoside Rg5, K, and ginsenoside Re have antidepressant or anxiolytic effects, and ginsenoside Rh1and pseudoginsenoside-F(11) have anxiolytic effects. These components may exert these effects through regulating neurotransmitter mechanism (5-HT, DA, NE), modulation of the gamma-amino butyric acid (GABA) neurotransmission, glutamatergic system, hypo-thalamus-pituitary-adrenal (HPA) axis, brain-derived neurotrophic factor (BDNF), and its intracellular signaling pathways in the central nervous system; and produce neuronal protection by anti-inflammatory, anti-oxidation, inhibition of neuronal apoptosis, or platelet aggregation and its intracellular signaling pathways. </text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>19888</offset><text>Although, among them, some compounds have been only proved to have antidepressant or anxiolytic effects in GTS, the main chemical composition of Panax notoginseng (Burk) F. H. Chen is similar to that of ginseng; at present, less researches have been shown on the role of Panax notoginseng (Burk) F. H. Chen and chemical composition in anti-anxiety and anti-depression. Therefore, as a potential new drug, a systematic and in-depth study of the effects and its molecular mechanisms of anti-anxiety and anti-depression of Panax notoginseng (Burk) F. H. Chen is needed. </text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>20456</offset><text>Further work on elucidation of the structure-function relationship among saponins, understanding of multi-target network pharmacology of Panax notoginseng (Burk) F. H. Chen with Network Pharmacology tools, as well as developing its new clinical usage and comprehensive utilize will enhance the therapeutic potentials of Panax notoginseng (Burk) F. H. Chen. A clearer understanding of the mechanisms underlying the effects of Panax notoginseng (Burk) F. H. Chen on human cytokine/metabolic systems and on stress-induced hormonal changes could facilitate the development of a wide range of treatments for patients with psychological and physical diseases.</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title</infon><offset>21112</offset><text>Conflicts of Interest</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>21134</offset><text>The authors declare no conflicts of interest.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>21180</offset><text>References</text></passage><passage><infon key="fpage">101</infon><infon key="lpage">111</infon><infon key="name_0">surname:Dean;given-names:J.</infon><infon key="name_1">surname:Keshavan;given-names:M.</infon><infon key="pub-id_doi">10.1016/j.ajp.2017.01.025</infon><infon key="pub-id_pmid">28558878</infon><infon key="section_type">REF</infon><infon key="source">Asian J. Psychiatry</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2017</infon><offset>21191</offset><text>The neurobiology of depression: An integrated view</text></passage><passage><infon key="fpage">949</infon><infon key="lpage">954</infon><infon key="name_0">surname:Dell'Osso;given-names:L.</infon><infon key="name_1">surname:Carmassi;given-names:C.</infon><infon key="name_2">surname:Mucci;given-names:F.</infon><infon key="name_3">surname:Marazziti;given-names:D.</infon><infon key="pub-id_doi">10.2174/1381612822666151214104826</infon><infon key="pub-id_pmid">26654774</infon><infon key="section_type">REF</infon><infon key="source">Curr. Pharm. Des.</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2016</infon><offset>21242</offset><text>Depression, Serotonin and Tryptophan</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">18</infon><infon key="name_0">surname:Dunn;given-names:E.C.</infon><infon key="name_1">surname:Brown;given-names:R.C.</infon><infon key="name_2">surname:Dai;given-names:Y.</infon><infon key="name_3">surname:Rosand;given-names:J.</infon><infon key="name_4">surname:Nugent;given-names:N.R.</infon><infon key="name_5">surname:Amstadter;given-names:A.B.</infon><infon key="name_6">surname:Smoller;given-names:J.W.</infon><infon key="pub-id_doi">10.1097/HRP.0000000000000054</infon><infon key="pub-id_pmid">25563565</infon><infon key="section_type">REF</infon><infon key="source">Harv. Rev. Psychiatry</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2015</infon><offset>21279</offset><text>Genetic determinants of depression: Recent findings and future directions</text></passage><passage><infon key="fpage">899</infon><infon key="lpage">906</infon><infon key="name_0">surname:Hashmi;given-names:A.M.</infon><infon key="name_1">surname:Butt;given-names:Z.</infon><infon key="name_2">surname:Umair;given-names:M.</infon><infon key="pub-id_pmid">23901717</infon><infon key="section_type">REF</infon><infon key="source">J. Pak. Med. Assoc.</infon><infon key="type">ref</infon><infon key="volume">63</infon><infon key="year">2013</infon><offset>21353</offset><text>Is depression an inflammatory condition? A review of available evidence</text></passage><passage><infon key="fpage">2861</infon><infon key="lpage">2867</infon><infon key="name_0">surname:Catena-Dell'Osso;given-names:M.</infon><infon key="name_1">surname:Caserta;given-names:A.</infon><infon key="name_2">surname:Baroni;given-names:S.</infon><infon key="name_3">surname:Nisita;given-names:C.</infon><infon key="name_4">surname:Marazziti;given-names:D.</infon><infon key="pub-id_pmid">23521673</infon><infon key="section_type">REF</infon><infon key="source">Curr. Med. Chem.</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2013</infon><offset>21425</offset><text>The relationship between epilepsy and depression: An update</text></passage><passage><infon key="fpage">80</infon><infon key="lpage">91</infon><infon key="name_0">surname:Limon;given-names:A.</infon><infon key="name_1">surname:Mamdani;given-names:F.</infon><infon key="name_2">surname:Hjelm;given-names:B.E.</infon><infon key="name_3">surname:Vawter;given-names:M.P.</infon><infon key="name_4">surname:Sequeira;given-names:A.</infon><infon key="pub-id_doi">10.1016/j.neubiorev.2016.04.010</infon><infon key="pub-id_pmid">27108532</infon><infon key="section_type">REF</infon><infon key="source">Neurosci. Biobehav. Rev.</infon><infon key="type">ref</infon><infon key="volume">66</infon><infon key="year">2016</infon><offset>21485</offset><text>Targets of polyamine dysregulation in major depression and suicide: Activity-dependent feedback, excitability, and neurotransmission</text></passage><passage><infon key="fpage">845</infon><infon key="lpage">855</infon><infon key="name_0">surname:Novais;given-names:F.</infon><infon key="name_1">surname:Starkstein;given-names:S.</infon><infon key="pub-id_doi">10.3233/JAD-148004</infon><infon key="pub-id_pmid">26401763</infon><infon key="section_type">REF</infon><infon key="source">J. Alzheimers Dis.</infon><infon key="type">ref</infon><infon key="volume">47</infon><infon key="year">2015</infon><offset>21618</offset><text>Phenomenology of Depression in Alzheimer's Disease</text></passage><passage><infon key="fpage">932757</infon><infon key="name_0">surname:Stepanichev;given-names:M.</infon><infon key="name_1">surname:Dygalo;given-names:N.N.</infon><infon key="name_2">surname:Grigoryan;given-names:G.</infon><infon key="name_3">surname:Shishkina;given-names:G.T.</infon><infon key="name_4">surname:Gulyaeva;given-names:N.</infon><infon key="pub-id_doi">10.1155/2014/932757</infon><infon key="pub-id_pmid">24999483</infon><infon key="section_type">REF</infon><infon key="source">BioMed Res. Int.</infon><infon key="type">ref</infon><infon key="volume">2014</infon><infon key="year">2014</infon><offset>21671</offset><text>Rodent models of depression: Neurotrophic and neuroinflammatory biomarkers</text></passage><passage><infon key="name_0">surname:Uchida;given-names:S.</infon><infon key="name_1">surname:Yamagata;given-names:H.</infon><infon key="name_2">surname:Seki;given-names:T.</infon><infon key="name_3">surname:Watanabe;given-names:Y.</infon><infon key="pub-id_doi">10.1111/pcn.12621</infon><infon key="pub-id_pmid">29154458</infon><infon key="section_type">REF</infon><infon key="source">Psychiatry Clin. Neurosci.</infon><infon key="type">ref</infon><infon key="year">2017</infon><offset>21746</offset><text>Epigenetic mechanisms of major depression: Targeting neuronal plasticity</text></passage><passage><infon key="fpage">19406</infon><infon key="name_0">surname:Zheng;given-names:X.</infon><infon key="name_1">surname:Ma;given-names:S.</infon><infon key="name_2">surname:Kang;given-names:A.</infon><infon key="name_3">surname:Wu;given-names:M.</infon><infon key="name_4">surname:Wang;given-names:L.</infon><infon key="name_5">surname:Wang;given-names:Q.</infon><infon key="name_6">surname:Wang;given-names:G.</infon><infon key="name_7">surname:Hao;given-names:H.</infon><infon key="pub-id_doi">10.1038/srep19406</infon><infon key="pub-id_pmid">26783261</infon><infon key="section_type">REF</infon><infon key="source">Sci. Rep.</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">2016</infon><offset>21819</offset><text>Chemical dampening of Ly6C(hi) monocytes in the periphery produces anti-depressant effects in mice</text></passage><passage><infon key="fpage">752</infon><infon key="name_0">surname:Zong;given-names:S.</infon><infon key="name_1">surname:Hoffmann;given-names:C.</infon><infon key="name_2">surname:Mane-Damas;given-names:M.</infon><infon key="name_3">surname:Molenaar;given-names:P.</infon><infon key="name_4">surname:Losen;given-names:M.</infon><infon key="name_5">surname:Martinez;given-names:P.</infon><infon key="pub-id_doi">10.3389/fimmu.2017.00752</infon><infon key="pub-id_pmid">28725222</infon><infon key="section_type">REF</infon><infon key="source">Front. Immunol.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2017</infon><offset>21918</offset><text>Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?</text></passage><passage><infon key="fpage">739</infon><infon key="lpage">755</infon><infon key="name_0">surname:Chi;given-names:S.</infon><infon key="name_1">surname:Yu;given-names:J.T.</infon><infon key="name_2">surname:Tan;given-names:M.S.</infon><infon key="name_3">surname:Tan;given-names:L.</infon><infon key="pub-id_pmid">24946876</infon><infon key="section_type">REF</infon><infon key="source">J. Alzheimers Dis.</infon><infon key="type">ref</infon><infon key="volume">42</infon><infon key="year">2014</infon><offset>22020</offset><text>Depression in Alzheimer's disease: Epidemiology, mechanisms, and management</text></passage><passage><infon key="fpage">139</infon><infon key="lpage">150</infon><infon key="name_0">surname:Flaster;given-names:M.</infon><infon key="name_1">surname:Sharma;given-names:A.</infon><infon key="name_2">surname:Rao;given-names:M.</infon><infon key="pub-id_doi">10.1310/tsr2002-139</infon><infon key="pub-id_pmid">23611855</infon><infon key="section_type">REF</infon><infon key="source">Top. Stroke Rehabil.</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2013</infon><offset>22098</offset><text>Poststroke depression: A review emphasizing the role of prophylactic treatment and synergy with treatment for motor recovery</text></passage><passage><infon key="fpage">104</infon><infon key="lpage">109</infon><infon key="name_0">surname:Li;given-names:W.</infon><infon key="name_1">surname:Ling;given-names:S.</infon><infon key="name_2">surname:Yang;given-names:Y.</infon><infon key="name_3">surname:Hu;given-names:Z.</infon><infon key="name_4">surname:Davies;given-names:H.</infon><infon key="name_5">surname:Fang;given-names:M.</infon><infon key="pub-id_pmid">24878979</infon><infon key="section_type">REF</infon><infon key="source">Neuro Endocrinol. Lett.</infon><infon key="type">ref</infon><infon key="volume">35</infon><infon key="year">2014</infon><offset>22223</offset><text>Systematic hypothesis for post-stroke depression caused inflammation and neurotransmission and resultant on possible treatments</text></passage><passage><infon key="fpage">67</infon><infon key="lpage">79</infon><infon key="name_0">surname:Benson;given-names:C.</infon><infon key="name_1">surname:Mifflin;given-names:K.</infon><infon key="name_2">surname:Kerr;given-names:B.</infon><infon key="name_3">surname:Jesudasan;given-names:S.J.</infon><infon key="name_4">surname:Dursun;given-names:S.</infon><infon key="name_5">surname:Baker;given-names:G.</infon><infon key="pub-id_pmid">26437459</infon><infon key="section_type">REF</infon><infon key="source">Mod. Trends Pharmacopsychiatry</infon><infon key="type">ref</infon><infon key="volume">30</infon><infon key="year">2015</infon><offset>22351</offset><text>Biogenic Amines and the Amino Acids GABA and Glutamate: Relationships with Pain and Depression</text></passage><passage><infon key="fpage">283</infon><infon key="lpage">293</infon><infon key="name_0">surname:Jeon;given-names:S.W.</infon><infon key="name_1">surname:Kim;given-names:Y.K.</infon><infon key="pub-id_doi">10.5498/wjp.v6.i3.283</infon><infon key="pub-id_pmid">27679767</infon><infon key="section_type">REF</infon><infon key="source">World J. Psychiatry</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">2016</infon><offset>22446</offset><text>Neuroinflammation and cytokine abnormality in major depression: Cause or consequence in that illness?</text></passage><passage><infon key="fpage">44</infon><infon key="lpage">49</infon><infon key="name_0">surname:Oakes;given-names:P.</infon><infon key="name_1">surname:Loukas;given-names:M.</infon><infon key="name_2">surname:Oskouian;given-names:R.J.</infon><infon key="name_3">surname:Tubbs;given-names:R.S.</infon><infon key="pub-id_doi">10.1002/ca.22781</infon><infon key="pub-id_pmid">27576673</infon><infon key="section_type">REF</infon><infon key="source">Clin. Anat.</infon><infon key="type">ref</infon><infon key="volume">30</infon><infon key="year">2017</infon><offset>22548</offset><text>The neuroanatomy of depression: A review</text></passage><passage><infon key="fpage">567</infon><infon key="name_0">surname:Lin;given-names:F.B.</infon><infon key="name_1">surname:Hou;given-names:D.R.</infon><infon key="name_2">surname:Tang;given-names:Q.P.</infon><infon key="section_type">REF</infon><infon key="source">J. South. Med. Univ.</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">2016</infon><offset>22589</offset><text>Research progress of depression and the application of esketamine</text></passage><passage><infon key="fpage">45</infon><infon key="lpage">54</infon><infon key="name_0">surname:Zhang;given-names:H.</infon><infon key="name_1">surname:Zhou;given-names:Z.</infon><infon key="name_2">surname:Chen;given-names:Z.</infon><infon key="name_3">surname:Zhong;given-names:Z.</infon><infon key="name_4">surname:Li;given-names:Z.</infon><infon key="pub-id_doi">10.1016/j.jphs.2017.03.007</infon><infon key="pub-id_pmid">28461003</infon><infon key="section_type">REF</infon><infon key="source">J. Pharmacol. Sci.</infon><infon key="type">ref</infon><infon key="volume">134</infon><infon key="year">2017</infon><offset>22655</offset><text>Ginsenoside Rg3 exerts anti-depressive effect on an NMDA-treated cell model and a chronic mild stress animal model</text></passage><passage><infon key="fpage">151</infon><infon key="name_0">surname:Allison;given-names:D.J.</infon><infon key="name_1">surname:Ditor;given-names:D.S.</infon><infon key="pub-id_doi">10.1186/s12974-014-0151-1</infon><infon key="pub-id_pmid">25178630</infon><infon key="section_type">REF</infon><infon key="source">J. Neuroinflamm.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2014</infon><offset>22770</offset><text>The common inflammatory etiology of depression and cognitive impairment: A therapeutic target</text></passage><passage><infon key="fpage">771</infon><infon key="lpage">783</infon><infon key="name_0">surname:Anderson;given-names:G.</infon><infon key="name_1">surname:Maes;given-names:M.</infon><infon key="pub-id_doi">10.1007/s12035-013-8554-z</infon><infon key="pub-id_pmid">24085563</infon><infon key="section_type">REF</infon><infon key="source">Mol. Neurobiol.</infon><infon key="type">ref</infon><infon key="volume">49</infon><infon key="year">2014</infon><offset>22864</offset><text>Neurodegeneration in Parkinson's disease: Interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins</text></passage><passage><infon key="fpage">137</infon><infon key="lpage">149</infon><infon key="name_0">surname:Anderson;given-names:G.</infon><infon key="name_1">surname:Maes;given-names:M.</infon><infon key="pub-id_doi">10.2174/18715273113129990082</infon><infon key="section_type">REF</infon><infon key="source">Disord. Drug Targets</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2014</infon><offset>23011</offset><text>TRYCAT pathways link peripheral inflammation, nicotine, somatization and depression in the etiology and course of Parkinson's disease. CNS Neurol</text></passage><passage><infon key="fpage">6142</infon><infon key="lpage">6151</infon><infon key="name_0">surname:Anderson;given-names:G.</infon><infon key="name_1">surname:Seo;given-names:M.</infon><infon key="name_2">surname:Berk;given-names:M.</infon><infon key="name_3">surname:Carvalho;given-names:A.F.</infon><infon key="name_4">surname:Maes;given-names:M.</infon><infon key="pub-id_doi">10.2174/1381612822666160906161513</infon><infon key="pub-id_pmid">27604608</infon><infon key="section_type">REF</infon><infon key="source">Curr. Pharm. Des.</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2016</infon><offset>23159</offset><text>Gut Permeability and Microbiota in Parkinson's Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic Pathways</text></passage><passage><infon key="fpage">218</infon><infon key="lpage">226</infon><infon key="name_0">surname:Braga;given-names:J.</infon><infon key="name_1">surname:Campar;given-names:A.</infon><infon key="pub-id_pmid">25326402</infon><infon key="section_type">REF</infon><infon key="source">Acta Reumatol. Port.</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">2014</infon><offset>23320</offset><text>Biological causes of depression in Systemic Lupus Erythematosus</text></passage><passage><infon key="fpage">697</infon><infon key="lpage">713</infon><infon key="name_0">surname:Cui;given-names:J.</infon><infon key="name_1">surname:Jiang;given-names:L.</infon><infon key="name_2">surname:Xiang;given-names:H.</infon><infon key="pub-id_doi">10.1177/0269881111415735</infon><infon key="pub-id_pmid">21948936</infon><infon key="section_type">REF</infon><infon key="source">J. Psychopharmacol.</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2012</infon><offset>23384</offset><text>Ginsenoside Rb3 exerts antidepressant-like effects in several animal models</text></passage><passage><infon key="fpage">731</infon><infon key="lpage">738</infon><infon key="name_0">surname:Xiang;given-names:H.</infon><infon key="name_1">surname:Liu;given-names:Y.</infon><infon key="name_2">surname:Zhang;given-names:B.</infon><infon key="name_3">surname:Huang;given-names:J.</infon><infon key="name_4">surname:Li;given-names:Y.</infon><infon key="name_5">surname:Yang;given-names:B.</infon><infon key="name_6">surname:Huang;given-names:Z.</infon><infon key="name_7">surname:Xiang;given-names:F.</infon><infon key="name_8">surname:Zhang;given-names:H.</infon><infon key="pub-id_doi">10.1016/j.phymed.2010.11.014</infon><infon key="pub-id_pmid">21273053</infon><infon key="section_type">REF</infon><infon key="source">Phytomedicine</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2011</infon><offset>23460</offset><text>The antidepressant effects and mechanism of action of total saponins from the caudexes and leaves of Panax notoginseng in animal models of depression</text></passage><passage><infon key="fpage">17</infon><infon key="lpage">26</infon><infon key="name_0">surname:Zhang;given-names:H.</infon><infon key="name_1">surname:Li;given-names:Z.</infon><infon key="name_2">surname:Zhou;given-names:Z.</infon><infon key="name_3">surname:Yang;given-names:H.</infon><infon key="name_4">surname:Zhong;given-names:Z.</infon><infon key="name_5">surname:Lou;given-names:C.</infon><infon key="pub-id_doi">10.1016/j.pbb.2015.10.018</infon><infon key="pub-id_pmid">26528894</infon><infon key="section_type">REF</infon><infon key="source">Pharmacol. Biochem. Behav.</infon><infon key="type">ref</infon><infon key="volume">140</infon><infon key="year">2016</infon><offset>23610</offset><text>Antidepressant-like effects of ginsenosides: A comparison of ginsenoside Rb3 and its four deglycosylated derivatives, Rg3, Rh2, K, and 20(S)-protopanaxadiol in mice models of despair</text></passage><passage><infon key="fpage">4516</infon><infon key="lpage">4521</infon><infon key="name_0">surname:Su;given-names:P.</infon><infon key="name_1">surname:Wang;given-names:L.</infon><infon key="name_2">surname:Du;given-names:S.J.</infon><infon key="name_3">surname:Xin;given-names:W.F.</infon><infon key="name_4">surname:Zhang;given-names:W.S.</infon><infon key="pub-id_pmid">25911793</infon><infon key="section_type">REF</infon><infon key="source">Zhongguo Zhong Yao Za Zhi</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">2014</infon><offset>23793</offset><text>Advance in studies of Panax notoginseng saponins on pharmacological mechanism of nervous system disease</text></passage><passage><infon key="fpage">699</infon><infon key="lpage">719</infon><infon key="name_0">surname:Bahramsoltani;given-names:R.</infon><infon key="name_1">surname:Farzaei;given-names:M.H.</infon><infon key="name_2">surname:Farahani;given-names:M.S.</infon><infon key="name_3">surname:Rahimi;given-names:R.</infon><infon key="pub-id_doi">10.1515/revneuro-2015-0009</infon><infon key="pub-id_pmid">26146123</infon><infon key="section_type">REF</infon><infon key="source">Rev. Neurosci.</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2015</infon><offset>23897</offset><text>Phytochemical constituents as future antidepressants: A comprehensive review</text></passage><passage><infon key="fpage">234</infon><infon key="lpage">258</infon><infon key="name_0">surname:Wang;given-names:T.</infon><infon key="name_1">surname:Guo;given-names:R.</infon><infon key="name_2">surname:Zhou;given-names:G.</infon><infon key="name_3">surname:Zhou;given-names:X.</infon><infon key="name_4">surname:Kou;given-names:Z.</infon><infon key="name_5">surname:Sui;given-names:F.</infon><infon key="name_6">surname:Li;given-names:C.</infon><infon key="name_7">surname:Tang;given-names:L.</infon><infon key="name_8">surname:Wang;given-names:Z.</infon><infon key="pub-id_doi">10.1016/j.jep.2016.05.005</infon><infon key="pub-id_pmid">27154405</infon><infon key="section_type">REF</infon><infon key="source">J. Ethnopharmacol.</infon><infon key="type">ref</infon><infon key="volume">188</infon><infon key="year">2016</infon><offset>23974</offset><text>Traditional uses, botany, phytochemistry, pharmacology and toxicology of Panax notoginseng (Burk.) F.H. Chen: A review</text></passage><passage><infon key="fpage">315</infon><infon key="lpage">324</infon><infon key="name_0">surname:Zhang;given-names:J.</infon><infon key="name_1">surname:Ding;given-names:L.</infon><infon key="name_2">surname:Wang;given-names:B.</infon><infon key="name_3">surname:Ren;given-names:G.</infon><infon key="name_4">surname:Sun;given-names:A.</infon><infon key="name_5">surname:Deng;given-names:C.</infon><infon key="name_6">surname:Wei;given-names:X.</infon><infon key="name_7">surname:Mani;given-names:S.</infon><infon key="name_8">surname:Wang;given-names:Z.</infon><infon key="name_9">surname:Dou;given-names:W.</infon><infon key="pub-id_doi">10.1124/jpet.114.218750</infon><infon key="pub-id_pmid">25472953</infon><infon key="section_type">REF</infon><infon key="source">J. Pharmacol. Exp. Ther.</infon><infon key="type">ref</infon><infon key="volume">352</infon><infon key="year">2015</infon><offset>24093</offset><text>Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation</text></passage><passage><infon key="fpage">210</infon><infon key="lpage">222</infon><infon key="name_0">surname:Zheng;given-names:X.</infon><infon key="name_1">surname:Liang;given-names:Y.</infon><infon key="name_2">surname:Kang;given-names:A.</infon><infon key="name_3">surname:Ma;given-names:S.J.</infon><infon key="name_4">surname:Xing;given-names:L.</infon><infon key="name_5">surname:Zhou;given-names:Y.Y.</infon><infon key="name_6">surname:Dai;given-names:C.</infon><infon key="name_7">surname:Xie;given-names:H.</infon><infon key="name_8">surname:Xie;given-names:L.</infon><infon key="name_9">surname:Wang;given-names:G.J.</infon><infon key="pub-id_doi">10.1016/j.neuroscience.2013.10.023</infon><infon key="pub-id_pmid">24161284</infon><infon key="section_type">REF</infon><infon key="source">Neuroscience</infon><infon key="type">ref</infon><infon key="volume">256</infon><infon key="year">2014</infon><offset>24198</offset><text>Peripheral immunomodulation with ginsenoside Rg1 ameliorates neuroinflammation-induced behavioral deficits in rats</text></passage><passage><infon key="fpage">42</infon><infon key="lpage">46</infon><infon key="name_0">surname:Kim;given-names:N.H.</infon><infon key="name_1">surname:Kim;given-names:K.Y.</infon><infon key="name_2">surname:Jeong;given-names:H.J.</infon><infon key="name_3">surname:Kim;given-names:H.M.</infon><infon key="pub-id_doi">10.1080/08964289.2011.566591</infon><infon key="pub-id_pmid">21660771</infon><infon key="section_type">REF</infon><infon key="source">Behav. Med.</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">2011</infon><offset>24313</offset><text>Antidepressant-like effect of altered Korean red ginseng in mice</text></passage><passage><infon key="fpage">1124</infon><infon key="lpage">1129</infon><infon key="name_0">surname:Xie;given-names:T.</infon><infon key="name_1">surname:Zhou;given-names:X.P.</infon><infon key="name_2">surname:Lin;given-names:L.L.</infon><infon key="name_3">surname:Xu;given-names:J.Y.</infon><infon key="name_4">surname:Shen;given-names:C.S.</infon><infon key="name_5">surname:Feng;given-names:Z.</infon><infon key="name_6">surname:Zhou;given-names:L.L.</infon><infon key="name_7">surname:Shan;given-names:J.J.</infon><infon key="pub-id_pmid">28875681</infon><infon key="section_type">REF</infon><infon key="source">Zhongguo Zhong Yao Za Zhi</infon><infon key="type">ref</infon><infon key="volume">41</infon><infon key="year">2016</infon><offset>24378</offset><text>Metabolomics analysis of Tripterygium wilfordii formulation based on theory of detoxicity compatibility</text></passage><passage><infon key="fpage">343</infon><infon key="lpage">352</infon><infon key="name_0">surname:Pang;given-names:H.H.</infon><infon key="name_1">surname:Li;given-names:M.Y.</infon><infon key="name_2">surname:Wang;given-names:Y.</infon><infon key="name_3">surname:Tang;given-names:M.K.</infon><infon key="name_4">surname:Ma;given-names:C.H.</infon><infon key="name_5">surname:Huang;given-names:J.M.</infon><infon key="pub-id_doi">10.1631/jzus.B1600235</infon><infon key="pub-id_pmid">28378572</infon><infon key="section_type">REF</infon><infon key="source">J. Zhejiang Univ. Sci. B</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2017</infon><offset>24482</offset><text>Effect of compatible herbs on the pharmacokinetics of effective components of Panax notoginseng in Fufang Xueshuantong Capsule</text></passage><passage><infon key="fpage">136</infon><infon key="lpage">143</infon><infon key="name_0">surname:Tian;given-names:Z.</infon><infon key="name_1">surname:Pang;given-names:H.</infon><infon key="name_2">surname:Du;given-names:S.</infon><infon key="name_3">surname:Lu;given-names:Y.</infon><infon key="name_4">surname:Zhang;given-names:L.</infon><infon key="name_5">surname:Wu;given-names:H.</infon><infon key="name_6">surname:Guo;given-names:S.</infon><infon key="name_7">surname:Wang;given-names:M.</infon><infon key="name_8">surname:Zhang;given-names:Q.</infon><infon key="pub-id_doi">10.1016/j.jchromb.2016.12.007</infon><infon key="pub-id_pmid">27978468</infon><infon key="section_type">REF</infon><infon key="source">J. Chromatogr. B</infon><infon key="type">ref</infon><infon key="volume">1040</infon><infon key="year">2017</infon><offset>24609</offset><text>Effect of Panax notoginseng saponins on the pharmacokinetics of aspirin in rats</text></passage><passage><infon key="fpage">147</infon><infon key="lpage">151</infon><infon key="name_0">surname:Zhao;given-names:S.</infon><infon key="name_1">surname:Zheng;given-names:M.X.</infon><infon key="name_2">surname:Chen;given-names:H.E.</infon><infon key="name_3">surname:Wu;given-names:C.Y.</infon><infon key="name_4">surname:Wang;given-names:W.T.</infon><infon key="pub-id_doi">10.1007/s11655-014-1790-2</infon><infon key="pub-id_pmid">25523598</infon><infon key="section_type">REF</infon><infon key="source">Chin. J. Integr. Med.</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2015</infon><offset>24689</offset><text>Effect of panax notoginseng saponins injection on the p38MAPK pathway in lung tissue in a rat model of hypoxic pulmonary hypertension</text></passage><passage><infon key="fpage">1167</infon><infon key="lpage">1174</infon><infon key="name_0">surname:Hou;given-names:Q.L.</infon><infon key="name_1">surname:Wang;given-names:Y.</infon><infon key="name_2">surname:Li;given-names:Y.B.</infon><infon key="name_3">surname:Hu;given-names:X.L.</infon><infon key="name_4">surname:Wang;given-names:S.L.</infon><infon key="pub-id_pmid">29027434</infon><infon key="section_type">REF</infon><infon key="source">Zhongguo Zhong Yao Za Zhi</infon><infon key="type">ref</infon><infon key="volume">42</infon><infon key="year">2017</infon><offset>24823</offset><text>Protective effect of notoginsenoside R1 on neuron injury induced by OGD/R through ATF6/Akt signaling pathway</text></passage><passage><infon key="fpage">7829</infon><infon key="lpage">7834</infon><infon key="name_0">surname:Yang;given-names:X.</infon><infon key="name_1">surname:Yang;given-names:S.</infon><infon key="name_2">surname:Hong;given-names:C.</infon><infon key="name_3">surname:Yu;given-names:W.</infon><infon key="name_4">surname:Guonian;given-names:W.</infon><infon key="pub-id_doi">10.3892/mmr.2017.7519</infon><infon key="pub-id_pmid">28944861</infon><infon key="section_type">REF</infon><infon key="source">Mol. Med. Rep.</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2017</infon><offset>24932</offset><text>Panax Notoginseng Saponins attenuates sevofluraneinduced nerve cell injury by modulating AKT signaling pathway</text></passage><passage><infon key="fpage">331</infon><infon key="lpage">335</infon><infon key="name_0">surname:Oh;given-names:H.A.</infon><infon key="name_1">surname:Kim;given-names:D.-E.</infon><infon key="name_2">surname:Choi;given-names:H.J.</infon><infon key="name_3">surname:Kim;given-names:N.J.</infon><infon key="name_4">surname:Kim;given-names:D.-H.</infon><infon key="pub-id_doi">10.1248/bpb.b14-00669</infon><infon key="pub-id_pmid">25747994</infon><infon key="section_type">REF</infon><infon key="source">Biol. Pharm. Bull.</infon><infon key="type">ref</infon><infon key="volume">38</infon><infon key="year">2015</infon><offset>25043</offset><text>Anti-stress Effects of 20(S)-Protopanaxadiol and 20(S)-Protopanaxatriol in Immobilized Mice</text></passage><passage><infon key="fpage">3738</infon><infon key="lpage">3750</infon><infon key="name_0">surname:Albert;given-names:P.R.</infon><infon key="name_1">surname:Fiori;given-names:L.M.</infon><infon key="pub-id_doi">10.2174/13816128113196660740</infon><infon key="pub-id_pmid">24180393</infon><infon key="section_type">REF</infon><infon key="source">Curr. Pharm Des.</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2014</infon><offset>25135</offset><text>Transcriptional dys-regulation in anxiety and major depression: 5-HT1A gene promoter architecture as a therapeutic opportunity</text></passage><passage><infon key="fpage">700</infon><infon key="lpage">704</infon><infon key="name_0">surname:Liu;given-names:M.Y.</infon><infon key="name_1">surname:Zhang;given-names:L.J.</infon><infon key="name_2">surname:Liu;given-names:M.C.</infon><infon key="pub-id_pmid">27586978</infon><infon key="section_type">REF</infon><infon key="source">Zhonghua Nei Ke Za Zhi</infon><infon key="type">ref</infon><infon key="volume">55</infon><infon key="year">2016</infon><offset>25262</offset><text>Effect of ginsenoside pre-treatment on 5-hydroxytryptamine system in SD rats with myocardial infarction and depression</text></passage><passage><infon key="fpage">1872</infon><infon key="lpage">1887</infon><infon key="name_0">surname:Jiang;given-names:B.</infon><infon key="name_1">surname:Xiong;given-names:Z.</infon><infon key="name_2">surname:Yang;given-names:J.</infon><infon key="name_3">surname:Wang;given-names:W.</infon><infon key="name_4">surname:Wang;given-names:Y.</infon><infon key="name_5">surname:Hu;given-names:Z.L.</infon><infon key="name_6">surname:Wang;given-names:F.</infon><infon key="name_7">surname:Chen;given-names:J.G.</infon><infon key="pub-id_doi">10.1111/j.1476-5381.2012.01902.x</infon><infon key="pub-id_pmid">22335772</infon><infon key="section_type">REF</infon><infon key="source">Br. J. Pharmacol.</infon><infon key="type">ref</infon><infon key="volume">166</infon><infon key="year">2012</infon><offset>25381</offset><text>Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus</text></passage><passage><infon key="fpage">708</infon><infon key="lpage">720</infon><infon key="name_0">surname:Lee;given-names:B.</infon><infon key="name_1">surname:Shim;given-names:I.</infon><infon key="name_2">surname:Lee;given-names:H.</infon><infon key="name_3">surname:Hahm;given-names:D.H.</infon><infon key="pub-id_doi">10.4014/jmb.1112.12046</infon><infon key="pub-id_pmid">22561867</infon><infon key="section_type">REF</infon><infon key="source">J. Microbiol. Biotechnol.</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2012</infon><offset>25517</offset><text>Effect of ginsenoside Re on depression- and anxiety-like behaviors and cognition memory deficit induced by repeated immobilization in rats</text></passage><passage><infon key="fpage">358</infon><infon key="lpage">369</infon><infon key="name_0">surname:Liu;given-names:Z.</infon><infon key="name_1">surname:Qi;given-names:Y.</infon><infon key="name_2">surname:Cheng;given-names:Z.</infon><infon key="name_3">surname:Zhu;given-names:X.</infon><infon key="name_4">surname:Fan;given-names:C.</infon><infon key="name_5">surname:Yu;given-names:S.Y.</infon><infon key="pub-id_doi">10.1016/j.neuroscience.2016.02.050</infon><infon key="pub-id_pmid">26926964</infon><infon key="section_type">REF</infon><infon key="source">Neuroscience</infon><infon key="type">ref</infon><infon key="volume">322</infon><infon key="year">2016</infon><offset>25656</offset><text>The effects of ginsenoside Rg1 on chronic stress induced depression-like behaviors, BDNF expression and the phosphorylation of PKA and CREB in rats</text></passage><passage><infon key="fpage">256</infon><infon key="lpage">263</infon><infon key="name_0">surname:Si;given-names:Y.</infon><infon key="name_1">surname:Zhu;given-names:J.</infon><infon key="name_2">surname:Huang;given-names:X.</infon><infon key="name_3">surname:Zhu;given-names:P.</infon><infon key="name_4">surname:Xie;given-names:C.</infon><infon key="pub-id_doi">10.1016/j.jcma.2015.10.011</infon><infon key="pub-id_pmid">26915440</infon><infon key="section_type">REF</infon><infon key="source">J. Chin. Med. Assoc.</infon><infon key="type">ref</infon><infon key="volume">79</infon><infon key="year">2016</infon><offset>25804</offset><text>Effects of Panax notoginseng saponins on proliferation and differentiation of rat embryonic cortical neural stem cells</text></passage><passage><infon key="fpage">226</infon><infon key="lpage">235</infon><infon key="name_0">surname:Zhao;given-names:M.</infon><infon key="name_1">surname:Chen;given-names:L.</infon><infon key="name_2">surname:Yang;given-names:J.</infon><infon key="name_3">surname:Han;given-names:D.</infon><infon key="name_4">surname:Fang;given-names:D.</infon><infon key="name_5">surname:Qiu;given-names:X.</infon><infon key="name_6">surname:Yang;given-names:X.</infon><infon key="name_7">surname:Qiao;given-names:Z.</infon><infon key="name_8">surname:Ma;given-names:J.</infon><infon key="name_9">surname:Wang;given-names:L.</infon><infon key="pub-id_doi">10.1016/j.jad.2017.10.024</infon><infon key="pub-id_pmid">29102837</infon><infon key="section_type">REF</infon><infon key="source">J. Affect. Disord.</infon><infon key="type">ref</infon><infon key="volume">227</infon><infon key="year">2017</infon><offset>25923</offset><text>BDNF Val66Met polymorphism, life stress and depression: A meta-analysis of gene-environment interaction</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">10</infon><infon key="name_0">surname:Anderson;given-names:G.</infon><infon key="name_1">surname:Berk;given-names:M.</infon><infon key="name_2">surname:Dean;given-names:O.</infon><infon key="name_3">surname:Moylan;given-names:S.</infon><infon key="name_4">surname:Maes;given-names:M.</infon><infon key="pub-id_doi">10.1007/s40263-013-0119-1</infon><infon key="pub-id_pmid">24150993</infon><infon key="section_type">REF</infon><infon key="source">CNS Drugs</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="year">2014</infon><offset>26027</offset><text>Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications</text></passage><passage><infon key="fpage">101</infon><infon key="lpage">114</infon><infon key="name_0">surname:Anderson;given-names:G.</infon><infon key="name_1">surname:Maes;given-names:M.</infon><infon key="name_2">surname:Berk;given-names:M.</infon><infon key="pub-id_doi">10.1016/j.pnpbp.2012.07.016</infon><infon key="pub-id_pmid">22930036</infon><infon key="section_type">REF</infon><infon key="source">Prog. Neuropsychopharm. Biol. Psychiatry</infon><infon key="type">ref</infon><infon key="volume">42</infon><infon key="year">2013</infon><offset>26157</offset><text>Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways</text></passage><passage><infon key="fpage">1542</infon><infon key="name_0">surname:Choi;given-names:J.G.</infon><infon key="name_1">surname:Jin;given-names:Y.H.</infon><infon key="name_2">surname:Lee;given-names:H.</infon><infon key="name_3">surname:Oh;given-names:T.W.</infon><infon key="name_4">surname:Yim;given-names:N.H.</infon><infon key="name_5">surname:Cho;given-names:W.K.</infon><infon key="name_6">surname:Ma;given-names:J.Y.</infon><infon key="pub-id_doi">10.3389/fimmu.2017.01542</infon><infon key="pub-id_pmid">29181006</infon><infon key="section_type">REF</infon><infon key="source">Front. Immunol.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2017</infon><offset>26335</offset><text>Protective Effect of Panax notoginseng Root Water Extract against Influenza A Virus Infection by Enhancing Antiviral Interferon-Mediated Immune Responses and Natural Killer Cell Activity</text></passage><passage><infon key="fpage">146</infon><infon key="lpage">173</infon><infon key="name_0">surname:Han;given-names:J.Y.</infon><infon key="name_1">surname:Li;given-names:Q.</infon><infon key="name_2">surname:Ma;given-names:Z.Z.</infon><infon key="name_3">surname:Fan;given-names:J.Y.</infon><infon key="pub-id_doi">10.1016/j.pharmthera.2017.03.005</infon><infon key="pub-id_pmid">28322971</infon><infon key="section_type">REF</infon><infon key="source">Pharmacol. Ther.</infon><infon key="type">ref</infon><infon key="volume">177</infon><infon key="year">2017</infon><offset>26522</offset><text>Effects and mechanisms of compound Chinese medicine and major ingredients on microcirculatory dysfunction and organ injury induced by ischemia/reperfusion</text></passage><passage><infon key="fpage">100</infon><infon key="name_0">surname:Kang;given-names:A.</infon><infon key="name_1">surname:Hao;given-names:H.</infon><infon key="name_2">surname:Zheng;given-names:X.</infon><infon key="name_3">surname:Liang;given-names:Y.</infon><infon key="name_4">surname:Xie;given-names:Y.</infon><infon key="name_5">surname:Xie;given-names:T.</infon><infon key="name_6">surname:Dai;given-names:C.</infon><infon key="name_7">surname:Zhao;given-names:Q.</infon><infon key="name_8">surname:Wu;given-names:X.</infon><infon key="name_9">surname:Xie;given-names:L.</infon><infon key="pub-id_doi">10.1186/1742-2094-8-100</infon><infon key="pub-id_pmid">21843370</infon><infon key="section_type">REF</infon><infon key="source">J. Neuroinflamm.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2011</infon><offset>26677</offset><text>Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy</text></passage><passage><infon key="fpage">6861</infon><infon key="lpage">6869</infon><infon key="name_0">surname:Kang;given-names:A.</infon><infon key="name_1">surname:Xie;given-names:T.</infon><infon key="name_2">surname:Zhu;given-names:D.</infon><infon key="name_3">surname:Shan;given-names:J.</infon><infon key="name_4">surname:Di;given-names:L.</infon><infon key="name_5">surname:Zheng;given-names:X.</infon><infon key="pub-id_doi">10.1021/acs.jafc.7b02386</infon><infon key="pub-id_pmid">28762741</infon><infon key="section_type">REF</infon><infon key="source">J. Agric. Food Chem.</infon><infon key="type">ref</infon><infon key="volume">65</infon><infon key="year">2017</infon><offset>26808</offset><text>Suppressive Effect of Ginsenoside Rg3 against Lipopolysaccharide-Induced Depression-Like Behavior and Neuroinflammation in Mice</text></passage><passage><infon key="fpage">536</infon><infon key="lpage">544</infon><infon key="name_0">surname:Pan;given-names:L.</infon><infon key="name_1">surname:Zhang;given-names:Y.</infon><infon key="name_2">surname:Lu;given-names:J.</infon><infon key="name_3">surname:Geng;given-names:Z.</infon><infon key="name_4">surname:Jia;given-names:L.</infon><infon key="name_5">surname:Rong;given-names:X.</infon><infon key="name_6">surname:Wang;given-names:Z.</infon><infon key="name_7">surname:Zhao;given-names:Q.</infon><infon key="name_8">surname:Wu;given-names:R.</infon><infon key="name_9">surname:Chu;given-names:M.</infon><infon key="pub-id_doi">10.1007/s12265-015-9659-8</infon><infon key="pub-id_pmid">26525047</infon><infon key="section_type">REF</infon><infon key="source">J. Cardiovasc. Transl. Res.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2015</infon><offset>26936</offset><text>Panax Notoginseng Saponins Ameliorates Coxsackievirus B3-Induced Myocarditis by Activating the Cystathionine-gamma-Lyase/Hydrogen Sulfide Pathway</text></passage><passage><infon key="fpage">375</infon><infon key="lpage">384</infon><infon key="name_0">surname:Wang;given-names:J.</infon><infon key="name_1">surname:Lu;given-names:L.</infon><infon key="name_2">surname:Wang;given-names:Y.</infon><infon key="name_3">surname:Wu;given-names:Y.</infon><infon key="name_4">surname:Han;given-names:J.</infon><infon key="name_5">surname:Wang;given-names:W.</infon><infon key="name_6">surname:Li;given-names:C.</infon><infon key="name_7">surname:Tu;given-names:P.</infon><infon key="pub-id_doi">10.1016/j.jep.2015.11.023</infon><infon key="pub-id_pmid">26590099</infon><infon key="section_type">REF</infon><infon key="source">J. Ethnopharmacol.</infon><infon key="type">ref</infon><infon key="volume">176</infon><infon key="year">2015</infon><offset>27082</offset><text>Qishenyiqi Dropping Pill attenuates myocardial fibrosis in rats by inhibiting RAAS-mediated arachidonic acid inflammation</text></passage><passage><infon key="fpage">813</infon><infon key="lpage">819</infon><infon key="name_0">surname:Wenxi;given-names:D.</infon><infon key="name_1">surname:Shufang;given-names:D.</infon><infon key="name_2">surname:Xiaoling;given-names:Y.</infon><infon key="name_3">surname:Liming;given-names:Y.</infon><infon key="pub-id_doi">10.1016/j.phymed.2015.05.056</infon><infon key="pub-id_pmid">26220628</infon><infon key="section_type">REF</infon><infon key="source">Phytomedicine</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2015</infon><offset>27204</offset><text>Panax notoginseng saponins suppress radiation-induced osteoporosis by regulating bone formation and resorption</text></passage><passage><infon key="fpage">409</infon><infon key="lpage">412</infon><infon key="name_0">surname:Wu;given-names:J.X.</infon><infon key="name_1">surname:Chen;given-names:J.X.</infon><infon key="pub-id_pmid">3218533</infon><infon key="section_type">REF</infon><infon key="source">Zhongguo Yao Li Xue Bao</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">1988</infon><offset>27315</offset><text>Negative chronotropic and inotropic effects of Panax notoginseng saponins</text></passage><passage><infon key="fpage">2341</infon><infon key="lpage">2348</infon><infon key="name_0">surname:Ge;given-names:Z.R.</infon><infon key="name_1">surname:Xu;given-names:M.C.</infon><infon key="name_2">surname:Huang;given-names:Y.U.</infon><infon key="name_3">surname:Zhang;given-names:C.J.</infon><infon key="name_4">surname:Lin;given-names:J.E.</infon><infon key="name_5">surname:Ruan;given-names:C.W.</infon><infon key="pub-id_doi">10.3892/etm.2016.3222</infon><infon key="pub-id_pmid">27284318</infon><infon key="section_type">REF</infon><infon key="source">Exp. Ther. Med.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2016</infon><offset>27389</offset><text>Cardioprotective effect of notoginsenoside R1 in a rabbit lung remote ischemic postconditioning model via activation of the TGF-beta1/TAK1 signaling pathway</text></passage><passage><infon key="fpage">232</infon><infon key="lpage">239</infon><infon key="name_0">surname:Wang;given-names:T.</infon><infon key="name_1">surname:Wan;given-names:D.</infon><infon key="name_2">surname:Shao;given-names:L.</infon><infon key="name_3">surname:Dai;given-names:J.</infon><infon key="name_4">surname:Jiang;given-names:C.</infon><infon key="pub-id_doi">10.1016/j.bbrc.2015.09.014</infon><infon key="pub-id_pmid">26362186</infon><infon key="section_type">REF</infon><infon key="source">Biochem. Biophys. Res. Commun.</infon><infon key="type">ref</infon><infon key="volume">466</infon><infon key="year">2015</infon><offset>27546</offset><text>Notoginsenoside R1 stimulates osteogenic function in primary osteoblasts via estrogen receptor signaling</text></passage><passage><infon key="fpage">3998</infon><infon key="lpage">4006</infon><infon key="name_0">surname:Wang;given-names:Y.</infon><infon key="name_1">surname:Ren;given-names:Y.</infon><infon key="name_2">surname:Xing;given-names:L.</infon><infon key="name_3">surname:Dai;given-names:X.</infon><infon key="name_4">surname:Liu;given-names:S.</infon><infon key="name_5">surname:Yu;given-names:B.</infon><infon key="name_6">surname:Wang;given-names:Y.</infon><infon key="pub-id_doi">10.3892/etm.2016.3890</infon><infon key="pub-id_pmid">28101178</infon><infon key="section_type">REF</infon><infon key="source">Exp. Ther. Med.</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2016</infon><offset>27651</offset><text>Endothelium-dependent vasodilation effects of Panax notoginseng and its main components are mediated by nitric oxide and cyclooxygenase pathways</text></passage><passage><infon key="fpage">799</infon><infon key="lpage">816</infon><infon key="name_0">surname:Xu;given-names:Y.</infon><infon key="name_1">surname:Lin;given-names:L.</infon><infon key="name_2">surname:Tang;given-names:L.</infon><infon key="name_3">surname:Zheng;given-names:M.</infon><infon key="name_4">surname:Ma;given-names:Y.</infon><infon key="name_5">surname:Huang;given-names:L.</infon><infon key="name_6">surname:Meng;given-names:W.</infon><infon key="name_7">surname:Wang;given-names:W.</infon><infon key="pub-id_doi">10.1142/S0192415X14500517</infon><infon key="pub-id_pmid">25004876</infon><infon key="section_type">REF</infon><infon key="source">Am. J. Chin. Med.</infon><infon key="type">ref</infon><infon key="volume">42</infon><infon key="year">2014</infon><offset>27796</offset><text>Notoginsenoside R1 attenuates hypoxia and hypercapnia-induced vasoconstriction in isolated rat pulmonary arterial rings by reducing the expression of ERK</text></passage><passage><infon key="fpage">300</infon><infon key="lpage">306</infon><infon key="name_0">surname:Luo;given-names:J.</infon><infon key="name_1">surname:Min;given-names:S.</infon><infon key="name_2">surname:Wei;given-names:K.</infon><infon key="name_3">surname:Zhang;given-names:J.</infon><infon key="name_4">surname:Liu;given-names:Y.</infon><infon key="pub-id_doi">10.1016/j.psychres.2011.09.010</infon><infon key="pub-id_pmid">22410590</infon><infon key="section_type">REF</infon><infon key="source">Psychiatry Res.</infon><infon key="type">ref</infon><infon key="volume">198</infon><infon key="year">2012</infon><offset>27950</offset><text>Propofol interacts with stimulus intensities of electroconvulsive shock to regulate behavior and hippocampal BDNF in a rat model of depression</text></passage><passage><infon key="fpage">10</infon><infon key="lpage">17</infon><infon key="name_0">surname:Gazal;given-names:M.</infon><infon key="name_1">surname:Ortmann;given-names:C.F.</infon><infon key="name_2">surname:Martins;given-names:F.A.</infon><infon key="name_3">surname:Streck;given-names:E.L.</infon><infon key="name_4">surname:Quevedo;given-names:J.</infon><infon key="name_5">surname:de Campos;given-names:A.M.</infon><infon key="name_6">surname:Stefanello;given-names:F.M.</infon><infon key="name_7">surname:Kaster;given-names:M.P.</infon><infon key="name_8">surname:Ghisleni;given-names:G.</infon><infon key="name_9">surname:Reginatto;given-names:F.H.</infon><infon key="pub-id_doi">10.1016/j.brainresbull.2014.07.007</infon><infon key="pub-id_pmid">25108233</infon><infon key="section_type">REF</infon><infon key="source">Brain Res. Bull.</infon><infon key="type">ref</infon><infon key="volume">108</infon><infon key="year">2014</infon><offset>28093</offset><text>Antidepressant-like effects of aqueous extract from Cecropia pachystachya leaves in a mouse model of chronic unpredictable stress</text></passage><passage><infon key="fpage">205</infon><infon key="lpage">211</infon><infon key="name_0">surname:Pechlivanova;given-names:D.</infon><infon key="name_1">surname:Tchekalarova;given-names:J.</infon><infon key="name_2">surname:Nikolov;given-names:R.</infon><infon key="name_3">surname:Yakimova;given-names:K.</infon><infon key="pub-id_doi">10.1016/j.bbr.2010.01.037</infon><infon key="pub-id_pmid">20122970</infon><infon key="section_type">REF</infon><infon key="source">Behav. Brain Res.</infon><infon key="type">ref</infon><infon key="volume">209</infon><infon key="year">2010</infon><offset>28223</offset><text>Dose-dependent effects of caffeine on behavior and thermoregulation in a chronic unpredictable stress model of depression in rats</text></passage><passage><infon key="fpage">115</infon><infon key="lpage">120</infon><infon key="name_0">surname:Taksande;given-names:B.G.</infon><infon key="name_1">surname:Faldu;given-names:D.S.</infon><infon key="name_2">surname:Dixit;given-names:M.P.</infon><infon key="name_3">surname:Sakaria;given-names:J.N.</infon><infon key="name_4">surname:Aglawe;given-names:M.M.</infon><infon key="name_5">surname:Umekar;given-names:M.J.</infon><infon key="name_6">surname:Kotagale;given-names:N.R.</infon><infon key="pub-id_doi">10.1016/j.ejphar.2013.10.041</infon><infon key="pub-id_pmid">24183973</infon><infon key="section_type">REF</infon><infon key="source">Eur. J. Pharmacol.</infon><infon key="type">ref</infon><infon key="volume">720</infon><infon key="year">2013</infon><offset>28353</offset><text>Agmatine attenuates chronic unpredictable mild stress induced behavioral alteration in mice</text></passage><passage><infon key="fpage">219</infon><infon key="lpage">229</infon><infon key="name_0">surname:Shi;given-names:M.</infon><infon key="name_1">surname:Wang;given-names:J.Y.</infon><infon key="name_2">surname:Luo;given-names:F.</infon><infon key="pub-id_doi">10.1016/j.jpain.2009.07.002</infon><infon key="pub-id_pmid">20096641</infon><infon key="section_type">REF</infon><infon key="source">J. Pain</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2010</infon><offset>28445</offset><text>Depression shows divergent effects on evoked and spontaneous pain behaviors in rats</text></passage><passage><infon key="fpage">3117</infon><infon key="lpage">3121</infon><infon key="name_0">surname:Wu;given-names:H.F.</infon><infon key="name_1">surname:Zhu;given-names:C.H.</infon><infon key="name_2">surname:Guo;given-names:J.Y.</infon><infon key="pub-id_pmid">23311165</infon><infon key="section_type">REF</infon><infon key="source">Zhongguo Zhong Yao Za Zhi</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">2012</infon><offset>28529</offset><text>Effect of ginsenoside Rg1 on behaviors and hippocampal amino acids in depressive-like rats</text></passage><passage><infon key="fpage">160</infon><infon key="lpage">165</infon><infon key="name_0">surname:Carr;given-names:M.N.</infon><infon key="name_1">surname:Bekku;given-names:N.</infon><infon key="name_2">surname:Yoshimura;given-names:H.</infon><infon key="pub-id_doi">10.1016/j.ejphar.2005.12.014</infon><infon key="pub-id_pmid">16413533</infon><infon key="section_type">REF</infon><infon key="source">Eur. J. Pharmacol.</infon><infon key="type">ref</infon><infon key="volume">531</infon><infon key="year">2006</infon><offset>28620</offset><text>Identification of anxiolytic ingredients in ginseng root using the elevated plus-maze test in mice</text></passage><passage><infon key="fpage">1621</infon><infon key="lpage">1625</infon><infon key="name_0">surname:Cha;given-names:H.Y.</infon><infon key="name_1">surname:Park;given-names:J.H.</infon><infon key="name_2">surname:Hong;given-names:J.T.</infon><infon key="name_3">surname:Yoo;given-names:H.S.</infon><infon key="name_4">surname:Song;given-names:S.</infon><infon key="name_5">surname:Hwang;given-names:B.Y.</infon><infon key="name_6">surname:Eun;given-names:J.S.</infon><infon key="name_7">surname:Oh;given-names:K.W.</infon><infon key="pub-id_doi">10.1248/bpb.28.1621</infon><infon key="pub-id_pmid">16141527</infon><infon key="section_type">REF</infon><infon key="source">Biol. Pharm. Bull.</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="year">2005</infon><offset>28719</offset><text>Anxiolytic-like effects of ginsenosides on the elevated plus-maze model in mice</text></passage><passage><infon key="fpage">1419</infon><infon key="lpage">1438</infon><infon key="name_0">surname:Huang;given-names:X.P.</infon><infon key="name_1">surname:Ding;given-names:H.</infon><infon key="name_2">surname:Lu;given-names:J.D.</infon><infon key="name_3">surname:Tang;given-names:Y.H.</infon><infon key="name_4">surname:Deng;given-names:B.X.</infon><infon key="name_5">surname:Deng;given-names:C.Q.</infon><infon key="pub-id_doi">10.1142/S0192415X15500809</infon><infon key="pub-id_pmid">26477799</infon><infon key="section_type">REF</infon><infon key="source">Am. J. Chin. Med.</infon><infon key="type">ref</infon><infon key="volume">43</infon><infon key="year">2015</infon><offset>28799</offset><text>Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion</text></passage><passage><infon key="fpage">732</infon><infon key="lpage">739</infon><infon key="name_0">surname:Huang;given-names:X.P.</infon><infon key="name_1">surname:Ding;given-names:H.</infon><infon key="name_2">surname:Wang;given-names:B.</infon><infon key="name_3">surname:Qiu;given-names:Y.Y.</infon><infon key="name_4">surname:Tang;given-names:Y.H.</infon><infon key="name_5">surname:Zeng;given-names:R.</infon><infon key="name_6">surname:Deng;given-names:C.Q.</infon><infon key="pub-id_pmid">26600717</infon><infon key="section_type">REF</infon><infon key="source">Pharmacogn. Mag.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2015</infon><offset>28972</offset><text>Effects of the main active components combinations of Astragalus and Panax notoginseng on energy metabolism in brain tissues after cerebral ischemia-reperfusion in mice</text></passage><passage><infon key="elocation-id">174</infon><infon key="name_0">surname:Qi;given-names:H.</infon><infon key="name_1">surname:Huang;given-names:Y.</infon><infon key="name_2">surname:Yang;given-names:Y.</infon><infon key="name_3">surname:Dou;given-names:G.</infon><infon key="name_4">surname:Wan;given-names:F.</infon><infon key="name_5">surname:Zhang;given-names:W.</infon><infon key="name_6">surname:Yang;given-names:H.</infon><infon key="name_7">surname:Wang;given-names:L.</infon><infon key="name_8">surname:Wu;given-names:C.</infon><infon key="name_9">surname:Li;given-names:L.</infon><infon key="pub-id_doi">10.1186/s12906-016-1160-7</infon><infon key="pub-id_pmid">27277000</infon><infon key="section_type">REF</infon><infon key="source">BMC Complement. Altern. Med.</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2016</infon><offset>29141</offset><text>Anti-platelet activity of panaxatriol saponins is mediated by suppression of intracellular calcium mobilization and ERK2/p38 activation</text></passage><passage><infon key="fpage">117</infon><infon key="lpage">120</infon><infon key="name_0">surname:Li;given-names:Q.</infon><infon key="name_1">surname:Guan;given-names:Y.</infon><infon key="name_2">surname:Ma;given-names:H.J.</infon><infon key="name_3">surname:Guo;given-names:Z.</infon><infon key="name_4">surname:He;given-names:R.R.</infon><infon key="name_5">surname:Zhang;given-names:Y.</infon><infon key="pub-id_pmid">20476583</infon><infon key="section_type">REF</infon><infon key="source">Zhongguo Ying Yong Sheng Li Xue Za Zhi</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2010</infon><offset>29277</offset><text>Influences of Panax notoginsenosid on spontaneous contraction of small intestine smooth muscle of rabbits in vitro</text></passage><passage><infon key="fpage">367</infon><infon key="lpage">379</infon><infon key="name_0">surname:You;given-names:Z.</infon><infon key="name_1">surname:Yao;given-names:Q.</infon><infon key="name_2">surname:Shen;given-names:J.</infon><infon key="name_3">surname:Gu;given-names:Z.</infon><infon key="name_4">surname:Xu;given-names:H.</infon><infon key="name_5">surname:Wu;given-names:Z.</infon><infon key="name_6">surname:Chen;given-names:C.</infon><infon key="name_7">surname:Li;given-names:L.</infon><infon key="pub-id_doi">10.1007/s11418-016-1066-1</infon><infon key="pub-id_pmid">28013484</infon><infon key="section_type">REF</infon><infon key="source">J. Nat. Med.</infon><infon key="type">ref</infon><infon key="volume">71</infon><infon key="year">2017</infon><offset>29392</offset><text>Antidepressant-like effects of ginsenoside Rg3 in mice via activation of the hippocampal BDNF signaling cascade</text></passage><passage><infon key="fpage">398</infon><infon key="lpage">420</infon><infon key="name_0">surname:Leff-Gelman;given-names:P.</infon><infon key="name_1">surname:Mancilla-Herrera;given-names:I.</infon><infon key="name_2">surname:Flores-Ramos;given-names:M.</infon><infon key="name_3">surname:Cruz-Fuentes;given-names:C.</infon><infon key="name_4">surname:Reyes-Grajeda;given-names:J.P.</infon><infon key="name_5">surname:Garcia-Cuetara Mdel;given-names:P.</infon><infon key="name_6">surname:Bugnot-Perez;given-names:M.D.</infon><infon key="name_7">surname:Pulido-Ascencio;given-names:D.E.</infon><infon key="pub-id_doi">10.1007/s12264-016-0048-3</infon><infon key="pub-id_pmid">27432060</infon><infon key="section_type">REF</infon><infon key="source">Neurosci. Bull.</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2016</infon><offset>29504</offset><text>The Immune System and the Role of Inflammation in Perinatal Depression</text></passage><passage><infon key="fpage">3186</infon><infon key="lpage">3193</infon><infon key="name_0">surname:Wang;given-names:J.</infon><infon key="name_1">surname:Li;given-names:D.</infon><infon key="name_2">surname:Hou;given-names:J.</infon><infon key="name_3">surname:Lei;given-names:H.</infon><infon key="pub-id_pmid">29257264</infon><infon key="section_type">REF</infon><infon key="source">Mol. Med. Rep.</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2018</infon><offset>29575</offset><text>Protective effects of geniposide and ginsenoside Rg1 combination treatment on rats following cerebral ischemia are mediated via microglial microRNA1555p inhibition</text></passage><passage><infon key="fpage">1402</infon><infon key="lpage">1411</infon><infon key="name_0">surname:Xu;given-names:C.</infon><infon key="name_1">surname:Teng;given-names:J.</infon><infon key="name_2">surname:Chen;given-names:W.</infon><infon key="name_3">surname:Ge;given-names:Q.</infon><infon key="name_4">surname:Yang;given-names:Z.</infon><infon key="name_5">surname:Yu;given-names:C.</infon><infon key="name_6">surname:Yang;given-names:Z.</infon><infon key="name_7">surname:Jia;given-names:W.</infon><infon key="pub-id_doi">10.1016/j.pnpbp.2010.07.010</infon><infon key="pub-id_pmid">20647027</infon><infon key="section_type">REF</infon><infon key="source">Prog. Neuropsychopharmacol. Biol. Psychiatry</infon><infon key="type">ref</infon><infon key="volume">34</infon><infon key="year">2010</infon><offset>29739</offset><text>20(S)-protopanaxadiol, an active ginseng metabolite, exhibits strong antidepressant-like effects in animal tests</text></passage><passage><infon key="fpage">231</infon><infon key="lpage">236</infon><infon key="name_0">surname:Yin;given-names:S.</infon><infon key="name_1">surname:Cheng;given-names:Y.</infon><infon key="name_2">surname:Li;given-names:T.</infon><infon key="name_3">surname:Dong;given-names:M.</infon><infon key="name_4">surname:Zhao;given-names:H.</infon><infon key="name_5">surname:Liu;given-names:G.</infon><infon key="pub-id_doi">10.3109/13880209.2015.1029051</infon><infon key="pub-id_pmid">25834921</infon><infon key="section_type">REF</infon><infon key="source">Pharm. Biol.</infon><infon key="type">ref</infon><infon key="volume">54</infon><infon key="year">2016</infon><offset>29852</offset><text>Effects of notoginsenoside R1 on CYP1A2, CYP2C11, CYP2D1, and CYP3A1/2 activities in rats by cocktail probe drugs</text></passage><passage><infon key="fpage">12</infon><infon key="name_0">surname:Chen;given-names:W.</infon><infon key="name_1">surname:Dang;given-names:Y.</infon><infon key="name_2">surname:Zhu;given-names:C.</infon><infon key="pub-id_doi">10.1186/1749-8546-5-12</infon><infon key="pub-id_pmid">20331853</infon><infon key="section_type">REF</infon><infon key="source">Chin. Med.</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2010</infon><offset>29966</offset><text>Simultaneous determination of three major bioactive saponins of Panax notoginseng using liquid chromatography-tandem mass spectrometry and a pharmacokinetic study</text></passage><passage><infon key="fpage">291</infon><infon key="lpage">299</infon><infon key="name_0">surname:Ducottet;given-names:C.</infon><infon key="name_1">surname:Aubert;given-names:A.</infon><infon key="name_2">surname:Belzung;given-names:C.</infon><infon key="pub-id_doi">10.1016/j.bbr.2004.04.020</infon><infon key="pub-id_pmid">15364489</infon><infon key="section_type">REF</infon><infon key="source">Behav. Brain Res.</infon><infon key="type">ref</infon><infon key="volume">155</infon><infon key="year">2004</infon><offset>30129</offset><text>Susceptibility to subchronic unpredictable stress is related to individual reactivity to threat stimuli in mice</text></passage><passage><infon key="fpage">41082</infon><infon key="name_0">surname:Zhang;given-names:C.</infon><infon key="name_1">surname:Li;given-names:C.</infon><infon key="name_2">surname:Chen;given-names:S.</infon><infon key="name_3">surname:Li;given-names:Z.</infon><infon key="name_4">surname:Ma;given-names:L.</infon><infon key="name_5">surname:Jia;given-names:X.</infon><infon key="name_6">surname:Wang;given-names:K.</infon><infon key="name_7">surname:Bao;given-names:J.</infon><infon key="name_8">surname:Liang;given-names:Y.</infon><infon key="name_9">surname:Chen;given-names:M.</infon><infon key="pub-id_doi">10.1038/srep41082</infon><infon key="pub-id_pmid">28112228</infon><infon key="section_type">REF</infon><infon key="source">Sci. Rep.</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2017</infon><offset>30241</offset><text>Hormetic effect of panaxatriol saponins confers neuroprotection in PC12 cells and zebrafish through PI3K/AKT/mTOR and AMPK/SIRT1/FOXO3 pathways</text></passage><passage><infon key="fpage">301</infon><infon key="lpage">312</infon><infon key="name_0">surname:Shi;given-names:X.</infon><infon key="name_1">surname:Yu;given-names:W.</infon><infon key="name_2">surname:Yang;given-names:T.</infon><infon key="name_3">surname:Liu;given-names:W.</infon><infon key="name_4">surname:Zhao;given-names:Y.</infon><infon key="name_5">surname:Sun;given-names:Y.</infon><infon key="name_6">surname:Chai;given-names:L.</infon><infon key="name_7">surname:Gao;given-names:Y.</infon><infon key="name_8">surname:Dong;given-names:B.</infon><infon key="name_9">surname:Zhu;given-names:L.</infon><infon key="pub-id_doi">10.1016/j.jep.2016.06.017</infon><infon key="pub-id_pmid">27288754</infon><infon key="section_type">REF</infon><infon key="source">J. Ethnopharmacol.</infon><infon key="type">ref</infon><infon key="volume">190</infon><infon key="year">2016</infon><offset>30385</offset><text>Panax notoginseng saponins provide neuroprotection by regulating NgR1/RhoA/ROCK2 pathway expression, in vitro and in vivo</text></passage><passage><infon key="fpage">589</infon><infon key="lpage">599</infon><infon key="name_0">surname:Yamada;given-names:N.</infon><infon key="name_1">surname:Araki;given-names:H.</infon><infon key="name_2">surname:Yoshimura;given-names:H.</infon><infon key="pub-id_doi">10.1007/s00213-011-2252-1</infon><infon key="pub-id_pmid">21424694</infon><infon key="section_type">REF</infon><infon key="source">Psychopharmacology</infon><infon key="type">ref</infon><infon key="volume">216</infon><infon key="year">2011</infon><offset>30507</offset><text>Identification of antidepressant-like ingredients in ginseng root (Panax ginseng C.A. Meyer) using a menopausal depressive-like state in female mice: participation of 5-HT2A receptors</text></passage><passage><infon key="fpage">836</infon><infon key="lpage">839</infon><infon key="name_0">surname:Kim;given-names:T.W.</infon><infon key="name_1">surname:Choi;given-names:H.J.</infon><infon key="name_2">surname:Kim;given-names:N.J.</infon><infon key="name_3">surname:Kim;given-names:D.H.</infon><infon key="pub-id_doi">10.1055/s-0029-1185402</infon><infon key="pub-id_pmid">19266429</infon><infon key="section_type">REF</infon><infon key="source">Planta Med.</infon><infon key="type">ref</infon><infon key="volume">75</infon><infon key="year">2009</infon><offset>30691</offset><text>Anxiolytic-like effects of ginsenosides Rg3 and Rh2 from red ginseng in the elevated plus-maze model</text></passage><passage><infon key="fpage">97</infon><infon key="lpage">105</infon><infon key="name_0">surname:Xu;given-names:D.</infon><infon key="name_1">surname:Wang;given-names:C.</infon><infon key="name_2">surname:Zhao;given-names:W.</infon><infon key="name_3">surname:Gao;given-names:S.</infon><infon key="name_4">surname:Cui;given-names:Z.</infon><infon key="pub-id_doi">10.1016/j.neulet.2017.02.071</infon><infon key="pub-id_pmid">28257788</infon><infon key="section_type">REF</infon><infon key="source">Neurosci. Lett.</infon><infon key="type">ref</infon><infon key="volume">645</infon><infon key="year">2017</infon><offset>30792</offset><text>Antidepressant-like effects of ginsenoside Rg5 in mice: Involving of hippocampus BDNF signaling pathway</text></passage><passage><infon key="fpage">914</infon><infon key="lpage">916</infon><infon key="name_0">surname:Jiang;given-names:S.</infon><infon key="name_1">surname:Miao;given-names:B.</infon><infon key="name_2">surname:Song;given-names:X.</infon><infon key="name_3">surname:Jiang;given-names:Z.</infon><infon key="pub-id_doi">10.1016/j.jep.2010.10.030</infon><infon key="pub-id_pmid">20969942</infon><infon key="section_type">REF</infon><infon key="source">J. Ethnopharmacol.</infon><infon key="type">ref</infon><infon key="volume">133</infon><infon key="year">2011</infon><offset>30896</offset><text>Inactivation of GABA(A) receptor reduces ginsenoside Rb3 neuroprotection in mouse hippocampal slices after oxygen-glucose deprivation</text></passage><passage><infon key="fpage">27</infon><infon key="lpage">33</infon><infon key="name_0">surname:Cheong;given-names:J.H.</infon><infon key="name_1">surname:Song;given-names:M.-R.</infon><infon key="name_2">surname:Lee;given-names:Y.S.</infon><infon key="name_3">surname:Her;given-names:Y.</infon><infon key="name_4">surname:Yim;given-names:D.S.</infon><infon key="name_5">surname:Ko;given-names:H.S.</infon><infon key="name_6">surname:Ryu;given-names:Y.S.</infon><infon key="name_7">surname:Choi;given-names:E.J.</infon><infon key="name_8">surname:Yoon;given-names:S.Y.</infon><infon key="name_9">surname:Choi;given-names:J.H.</infon><infon key="section_type">REF</infon><infon key="source">Biomol. Ther.</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2007</infon><offset>31030</offset><text>Anxiolytic and Antidepressant Activities of Ginsenoside Rb1</text></passage><passage><infon key="fpage">178</infon><infon key="lpage">187</infon><infon key="name_0">surname:Churchill;given-names:J.D.</infon><infon key="name_1">surname:Gerson;given-names:J.L.</infon><infon key="name_2">surname:Hinton;given-names:K.A.</infon><infon key="name_3">surname:Mifek;given-names:J.L.</infon><infon key="name_4">surname:Walter;given-names:M.J.</infon><infon key="name_5">surname:Winslow;given-names:C.L.</infon><infon key="name_6">surname:Deyo;given-names:R.A.</infon><infon key="pub-id_doi">10.1007/BF02734180</infon><infon key="pub-id_pmid">12435210</infon><infon key="section_type">REF</infon><infon key="source">Integr. Physiol. Behav. Sci.</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">2002</infon><offset>31090</offset><text>The nootropic properties of ginseng saponin Rb1 are linked to effects on anxiety</text></passage><passage><infon key="fpage">993</infon><infon key="lpage">1000</infon><infon key="name_0">surname:Wang;given-names:Z.J.</infon><infon key="name_1">surname:Song;given-names:L.</infon><infon key="name_2">surname:Guo;given-names:L.C.</infon><infon key="name_3">surname:Yin;given-names:M.</infon><infon key="name_4">surname:Sun;given-names:Y.N.</infon><infon key="pub-id_doi">10.1248/yakushi.131.993</infon><infon key="pub-id_pmid">21628989</infon><infon key="section_type">REF</infon><infon key="source">Yakugaku Zasshi</infon><infon key="type">ref</infon><infon key="volume">131</infon><infon key="year">2011</infon><offset>31171</offset><text>Induction of differentiation by panaxydol in human hepatocarcinoma SMMC-7721 cells via cAMP and MAP kinase dependent mechanism</text></passage><passage><infon key="fpage">103</infon><infon key="lpage">109</infon><infon key="name_0">surname:Wu;given-names:C.F.</infon><infon key="name_1">surname:Liu;given-names:Y.L.</infon><infon key="name_2">surname:Song;given-names:M.</infon><infon key="name_3">surname:Liu;given-names:W.</infon><infon key="name_4">surname:Wang;given-names:J.H.</infon><infon key="name_5">surname:Li;given-names:X.</infon><infon key="name_6">surname:Yang;given-names:J.Y.</infon><infon key="pub-id_doi">10.1016/S0091-3057(03)00215-6</infon><infon key="pub-id_pmid">13679222</infon><infon key="section_type">REF</infon><infon key="source">Pharmacol. Biochem. Behav.</infon><infon key="type">ref</infon><infon key="volume">76</infon><infon key="year">2003</infon><offset>31298</offset><text>Protective effects of pseudoginsenoside-F11 on methamphetamine-induced neurotoxicity in mice</text></passage><passage><infon key="fpage">133</infon><infon key="lpage">144</infon><infon key="name_0">surname:Lee;given-names:B.</infon><infon key="name_1">surname:Sur;given-names:B.</infon><infon key="name_2">surname:Cho;given-names:S.G.</infon><infon key="name_3">surname:Yeom;given-names:M.</infon><infon key="name_4">surname:Shim;given-names:I.</infon><infon key="name_5">surname:Lee;given-names:H.</infon><infon key="name_6">surname:Hahm;given-names:D.H.</infon><infon key="pub-id_doi">10.1007/s11418-015-0943-3</infon><infon key="pub-id_pmid">26611866</infon><infon key="section_type">REF</infon><infon key="source">J. Nat. Med.</infon><infon key="type">ref</infon><infon key="volume">70</infon><infon key="year">2016</infon><offset>31391</offset><text>Ginsenoside Rb1 rescues anxiety-like responses in a rat model of post-traumatic stress disorder</text></passage><passage><infon key="fpage">119</infon><infon key="lpage">125</infon><infon key="name_0">surname:Lee;given-names:B.-H.</infon><infon key="name_1">surname:Kim;given-names:H.-J.</infon><infon key="name_2">surname:Chung;given-names:L.</infon><infon key="name_3">surname:Nah;given-names:S.-Y.</infon><infon key="pub-id_doi">10.1016/j.ejphar.2013.02.040</infon><infon key="pub-id_pmid">23499684</infon><infon key="section_type">REF</infon><infon key="source">Eur. J. Pharmacol.</infon><infon key="type">ref</infon><infon key="volume">705</infon><infon key="year">2013</infon><offset>31487</offset><text>Ginsenoside Rg(3) regulates GABA(A) receptor channel activity: Involvement of interaction with the gamma(2) subunit</text></passage><passage><infon key="fpage">40318</infon><infon key="name_0">surname:Yue;given-names:S.-J.</infon><infon key="name_1">surname:Xin;given-names:L.-T.</infon><infon key="name_2">surname:Fan;given-names:Y.-C.</infon><infon key="name_3">surname:Li;given-names:S.-J.</infon><infon key="name_4">surname:Tang;given-names:Y.-P.</infon><infon key="name_5">surname:Duan;given-names:J.-A.</infon><infon key="name_6">surname:Guan;given-names:H.-S.</infon><infon key="name_7">surname:Wang;given-names:C.-Y.</infon><infon key="pub-id_doi">10.1038/srep40318</infon><infon key="pub-id_pmid">28074863</infon><infon key="section_type">REF</infon><infon key="source">Sci. Rep.</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2017</infon><offset>31603</offset><text>Herb pair Danggui-Honghua: Mechanisms underlying blood stasis syndrome by system pharmacology approach</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">15</infon><infon key="name_0">surname:Li;given-names:J.</infon><infon key="name_1">surname:Zhao;given-names:P.</infon><infon key="name_2">surname:Li;given-names:Y.</infon><infon key="name_3">surname:Tian;given-names:Y.</infon><infon key="name_4">surname:Wang;given-names:Y.</infon><infon key="pub-id_doi">10.1038/srep15290</infon><infon key="pub-id_pmid">26469778</infon><infon key="section_type">REF</infon><infon key="source">Sci. Rep.</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2015</infon><offset>31706</offset><text>Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease</text></passage><passage><infon key="fpage">589</infon><infon key="lpage">594</infon><infon key="name_0">surname:Lee;given-names:S.</infon><infon key="name_1">surname:Rhee;given-names:D.K.</infon><infon key="pub-id_doi">10.1016/j.jgr.2017.01.010</infon><infon key="pub-id_pmid">29021708</infon><infon key="section_type">REF</infon><infon key="source">J. Ginseng Res.</infon><infon key="type">ref</infon><infon key="volume">41</infon><infon key="year">2017</infon><offset>31868</offset><text>Effects of ginseng on stress-related depression, anxiety, and the hypothalamic-pituitary-adrenal axis</text></passage><passage><infon key="file">molecules-23-00940-g001.jpg</infon><infon key="id">molecules-23-00940-f001</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>31970</offset><text>Compound-target network of Panax notoginseng (Burk) F. H. Chen. Edges represent protein-protein associations; protein-protein interactions are shown in grey, chemical-protein interactions in green, and interactions between chemicals in red; stronger associations are represented by thicker lines. Small nodes: protein of unknown 3D structure; large nodes: some 3D structure is known or predicted; colored nodes: query proteins and first shell of interactors; white nodes: second shell of interactors. The chemical groups and structures in the gray rectangles, such as carbon dioxide, oxygen, and HO-, suggest functional links and predictions for specific actions on with potentially acting protein targets and combined scores of predicted interactions presented by analysing the Experimental/Biochemical Data, Association in Curated Databases and Co-Mentioned in PubMed Abstracts, which illustrated the possibility of interaction between compounds and potential protein targets. Associations are meant to be specific and meaningful, i.e., Proteins jointly contribute to a shared function; this does not necessarily mean they are physically binding each other. Predicted models were constructed by STITCH, Swiss Target Prediction, and Herbal Ingredients' Targets database.</text></passage><passage><infon key="file">molecules-23-00940-g002.jpg</infon><infon key="id">molecules-23-00940-f002</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>33248</offset><text>Strong association actions of compound and predicted target network of Panax notoginseng (Burk) F. H. Chen. (A) represents re-center network or functional domain of compounds associated with BCL2-A1; (B) represents BCL2; (C) represents TP53; (D) represents NFKB1; BCL2-A1, BCL2, NF-kappa-B, and TP53 were predicted to have strong association actions of compound and predicted target network of Panax notoginseng (Burk) F. H. Chen, indicating that PNS may exert anti-depression and anti-anxiety effects through inflammatory regulation and anti-apoptotic pathway. Association action models were constructed by STITCH and PDB database.</text></passage><passage><infon key="file">molecules-23-00940-t001.xml</infon><infon key="id">molecules-23-00940-t001</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>33881</offset><text>Phytochemicals and mechanisms with antidepressant effects in Panax notoginseng saponins (PNS).</text></passage><passage><infon key="file">molecules-23-00940-t001.xml</infon><infon key="id">molecules-23-00940-t001</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Name&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Methods&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Models&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Neurobehavioral Effects and Mechanisms&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PNS (58.6%)&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;OFT; TST; FST; SPT &lt;xref rid=&quot;B26-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;26&lt;/xref&gt;&lt;xref rid=&quot;B53-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;53&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CMS-induced mice; CUMS-induced rats &lt;xref rid=&quot;B26-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;26&lt;/xref&gt;&lt;xref rid=&quot;B53-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;53&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  Immobility time in FST and TST;   sucrose intake in sucrose preference test;   level of animal activity;   Expression of BDNF&lt;xref rid=&quot;B40-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;40&lt;/xref&gt;&lt;xref rid=&quot;B60-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;60&lt;/xref&gt;&lt;xref rid=&quot;B68-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;68&lt;/xref&gt;&lt;xref rid=&quot;B69-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;69&lt;/xref&gt;&lt;xref rid=&quot;B70-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;70&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Purified PNS&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;SPT; OFT &lt;xref rid=&quot;B45-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;45&lt;/xref&gt;&lt;xref rid=&quot;B71-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;71&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CUMS-induced SD rats &lt;xref rid=&quot;B45-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;45&lt;/xref&gt;&lt;xref rid=&quot;B71-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;71&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Regulate upstream neural signal transduction pathways: AC/cAMP/PKA, TrKB/MAPK/PSK and Ca&lt;sup&gt;2+&lt;/sup&gt;/CaM/CaMK signaling pathway;&lt;break/&gt;  Concentration of Ca&lt;sup&gt;2+&lt;/sup&gt; in nerve cells;   release of neurotransmitter 5-HT, DA, and NE&lt;xref rid=&quot;B45-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;45&lt;/xref&gt;&lt;xref rid=&quot;B71-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;71&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PNS and GTS&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;FST; SPT&lt;xref rid=&quot;B53-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;53&lt;/xref&gt;&lt;xref rid=&quot;B75-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;75&lt;/xref&gt;&lt;xref rid=&quot;B76-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;76&lt;/xref&gt;&lt;xref rid=&quot;B77-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;77&lt;/xref&gt;&lt;xref rid=&quot;B78-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;78&lt;/xref&gt;.&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;LPS-induced KM mice; CD-1 mice &lt;xref rid=&quot;B53-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;53&lt;/xref&gt;&lt;xref rid=&quot;B75-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;75&lt;/xref&gt;&lt;xref rid=&quot;B76-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;76&lt;/xref&gt;&lt;xref rid=&quot;B77-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;77&lt;/xref&gt;&lt;xref rid=&quot;B78-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;78&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  mRNA of IL-1beta, IL-6, TNF-alpha, and IDO;   Inflammation in the brain&lt;xref rid=&quot;B53-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;53&lt;/xref&gt;&lt;xref rid=&quot;B75-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;75&lt;/xref&gt;&lt;xref rid=&quot;B76-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;76&lt;/xref&gt;&lt;xref rid=&quot;B77-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;77&lt;/xref&gt;&lt;xref rid=&quot;B78-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;78&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rg1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;OFT; FST; SPT &lt;xref rid=&quot;B19-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;19&lt;/xref&gt;&lt;xref rid=&quot;B45-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;45&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CMS and CUMS-induced depression Animal Model &lt;xref rid=&quot;B19-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;19&lt;/xref&gt;&lt;xref rid=&quot;B45-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;45&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  CMS-induced increasement of corticosterone levels in serum;   CUMS-induced CREB phosphorylation in the amygdala of the brain&lt;xref rid=&quot;B45-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;45&lt;/xref&gt;;   expression of BDNF&lt;xref rid=&quot;B33-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;33&lt;/xref&gt;&lt;xref rid=&quot;B43-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;43&lt;/xref&gt;; regulate hyperactivity of the HPA axis in depressed states;  neuronal status, neurons quantity and density of dendritic spines&lt;xref rid=&quot;B19-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;19&lt;/xref&gt;&lt;xref rid=&quot;B45-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;45&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rg1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;FST; SPT &lt;xref rid=&quot;B79-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;79&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CMS and CUMS-induced depression animal model &lt;xref rid=&quot;B80-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;80&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  Expression of connexin and gap junction of astrocytes in the prefrontal cortex of the brain;   dense ultrastructure;   permeability and depression-like behaviors induced by CUS in rats&lt;xref rid=&quot;B79-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;79&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rg1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;FST; SPT &lt;xref rid=&quot;B10-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;10&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cerebral inflammatory model mice &lt;xref rid=&quot;B10-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;10&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  Recruitment of Ly6C (hi) monocytes in inflammatory brain model mice&lt;xref rid=&quot;B10-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;10&lt;/xref&gt;&lt;xref rid=&quot;B16-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;16&lt;/xref&gt;; activate THP-1 monocytes; blocks the feedback-regulated release of CCL2 from astroglial cells;   CCL2 signaling pathways: p38/MAPK and PI3K/Akt activities&lt;xref rid=&quot;B10-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;10&lt;/xref&gt;&lt;xref rid=&quot;B81-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;81&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rg1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TST; FST; SPT &lt;xref rid=&quot;B15-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;15&lt;/xref&gt;&lt;xref rid=&quot;B67-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;67&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CUMS-induced depression rats &lt;xref rid=&quot;B67-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;67&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  Contents of Glu and Asp in hippocampus,   contents of GABA and Tau;   depression-like Behavior in CUMS model rats&lt;xref rid=&quot;B15-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;15&lt;/xref&gt;&lt;xref rid=&quot;B67-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;67&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rb1 and ginsenoside K&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TST; FST &lt;xref rid=&quot;B42-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;42&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CUMS-induced depression rats &lt;xref rid=&quot;B42-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;42&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  Expression of 5-HT2AR mRNA and activate of 5-HT2AR&lt;xref rid=&quot;B42-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;42&lt;/xref&gt;; the antidepressant effects of Rb1 and the metabolite ginsenoside K may be antagonized by 5-HT2AR antagonists (Ritanerin), indicating that Rb1 has a similar 5-HT transmitter activation effect&lt;xref rid=&quot;B68-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;68&lt;/xref&gt;&lt;xref rid=&quot;B82-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;82&lt;/xref&gt;&lt;xref rid=&quot;B83-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;83&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rg3 and ginsenoside Rh2&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;OFT; SPT &lt;xref rid=&quot;B19-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;19&lt;/xref&gt;&lt;xref rid=&quot;B53-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;53&lt;/xref&gt;&lt;xref rid=&quot;B74-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;74&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;LPS-induced mice&lt;xref rid=&quot;B19-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;19&lt;/xref&gt;&lt;xref rid=&quot;B53-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;53&lt;/xref&gt;&lt;xref rid=&quot;B74-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;74&lt;/xref&gt; and CSDS-induced mice &lt;xref rid=&quot;B74-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;74&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  IL-6 and TNF-alpha in plasma and the expression of indoleamine 2,3-dioxygenase (IDO) in brain;   turnover of tryptophan and 5-HT in hippocampal tissue; regulate secretory activities of microglia and transcription of NF-kappa-B in nuclear;   expression of BNDF;   depressive behavior or symptoms&lt;xref rid=&quot;B53-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;53&lt;/xref&gt;&lt;xref rid=&quot;B74-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;74&lt;/xref&gt;&lt;xref rid=&quot;B84-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;84&lt;/xref&gt;. &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rg5&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;OFT; FST; SPT &lt;xref rid=&quot;B85-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;85&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CSDS-induced mice &lt;xref rid=&quot;B85-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;85&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  Trk and AchE;  expression of BNDF&lt;xref rid=&quot;B69-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;69&lt;/xref&gt;&lt;xref rid=&quot;B85-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;85&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Re&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;OFT; TST &lt;xref rid=&quot;B44-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;44&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CMS-induced rat model &lt;xref rid=&quot;B44-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;44&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Regulate the central adrenergic system;   expression of TH in the locus coeruleus area;   decrease of BDNF in the hippocampus, and regulates the secretion of corticosterone from the HPA axis&lt;xref rid=&quot;B44-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;44&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>33976</offset><text>Name	Methods	Models	Neurobehavioral Effects and Mechanisms	 	PNS (58.6%)	OFT; TST; FST; SPT 	CMS-induced mice; CUMS-induced rats 	  Immobility time in FST and TST;   sucrose intake in sucrose preference test;   level of animal activity;   Expression of BDNF.	 	Purified PNS	SPT; OFT 	CUMS-induced SD rats 	Regulate upstream neural signal transduction pathways: AC/cAMP/PKA, TrKB/MAPK/PSK and Ca2+/CaM/CaMK signaling pathway;  Concentration of Ca2+ in nerve cells;   release of neurotransmitter 5-HT, DA, and NE.	 	PNS and GTS	FST; SPT.	LPS-induced KM mice; CD-1 mice 	  mRNA of IL-1beta, IL-6, TNF-alpha, and IDO;   Inflammation in the brain.	 	Ginsenoside Rg1	OFT; FST; SPT 	CMS and CUMS-induced depression Animal Model 	  CMS-induced increasement of corticosterone levels in serum;   CUMS-induced CREB phosphorylation in the amygdala of the brain;   expression of BDNF; regulate hyperactivity of the HPA axis in depressed states;  neuronal status, neurons quantity and density of dendritic spines.	 	Ginsenoside Rg1	FST; SPT 	CMS and CUMS-induced depression animal model 	  Expression of connexin and gap junction of astrocytes in the prefrontal cortex of the brain;   dense ultrastructure;   permeability and depression-like behaviors induced by CUS in rats.	 	Ginsenoside Rg1	FST; SPT 	Cerebral inflammatory model mice 	  Recruitment of Ly6C (hi) monocytes in inflammatory brain model mice; activate THP-1 monocytes; blocks the feedback-regulated release of CCL2 from astroglial cells;   CCL2 signaling pathways: p38/MAPK and PI3K/Akt activities.	 	Ginsenoside Rg1	TST; FST; SPT 	CUMS-induced depression rats 	  Contents of Glu and Asp in hippocampus,   contents of GABA and Tau;   depression-like Behavior in CUMS model rats	 	Ginsenoside Rb1 and ginsenoside K	TST; FST 	CUMS-induced depression rats 	  Expression of 5-HT2AR mRNA and activate of 5-HT2AR; the antidepressant effects of Rb1 and the metabolite ginsenoside K may be antagonized by 5-HT2AR antagonists (Ritanerin), indicating that Rb1 has a similar 5-HT transmitter activation effect.	 	Ginsenoside Rg3 and ginsenoside Rh2	OFT; SPT 	LPS-induced mice and CSDS-induced mice 	  IL-6 and TNF-alpha in plasma and the expression of indoleamine 2,3-dioxygenase (IDO) in brain;   turnover of tryptophan and 5-HT in hippocampal tissue; regulate secretory activities of microglia and transcription of NF-kappa-B in nuclear;   expression of BNDF;   depressive behavior or symptoms. 	 	Ginsenoside Rg5	OFT; FST; SPT 	CSDS-induced mice 	  Trk and AchE;  expression of BNDF.	 	Ginsenoside Re	OFT; TST 	CMS-induced rat model 	Regulate the central adrenergic system;   expression of TH in the locus coeruleus area;   decrease of BDNF in the hippocampus, and regulates the secretion of corticosterone from the HPA axis.	 	</text></passage><passage><infon key="file">molecules-23-00940-t001.xml</infon><infon key="id">molecules-23-00940-t001</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>36799</offset><text>GST, ginseng total saponin ; SPT, sucrose preference test; FST, forced swimming test; OFT, open field test; TST, tail suspension test; CMS, chronic mild stress; CUMS, chronic unpredictable mild stress; CREB, cAMP response element-binding protein; CSDS, chronic social defeat stress.</text></passage><passage><infon key="file">molecules-23-00940-t002.xml</infon><infon key="id">molecules-23-00940-t002</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>37082</offset><text>Phytochemicals and mechanisms with anxiolytic effects in Panax notoginseng saponins (PNS).</text></passage><passage><infon key="file">molecules-23-00940-t002.xml</infon><infon key="id">molecules-23-00940-t002</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Name&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Methods&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Models&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Neurobehavioral Effects and Mechanisms&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PNS&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;OFT; SPT &lt;xref rid=&quot;B26-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;26&lt;/xref&gt;&lt;xref rid=&quot;B28-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;28&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;l-DOPA-induced mice&lt;xref rid=&quot;B26-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;26&lt;/xref&gt;&lt;xref rid=&quot;B28-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;28&lt;/xref&gt;; 5-HTP-induced rats &lt;xref rid=&quot;B89-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;89&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  Basal [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;sub&gt;i&lt;/sub&gt; levels;   immobility time;   levels of 5-HT, DA and NE&lt;xref rid=&quot;B26-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;26&lt;/xref&gt;&lt;xref rid=&quot;B28-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;28&lt;/xref&gt;&lt;xref rid=&quot;B89-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;89&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rb1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;EPM test &lt;xref rid=&quot;B44-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;44&lt;/xref&gt;&lt;xref rid=&quot;B91-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;91&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;SPS model and rat model of post-traumatic stress disorder &lt;xref rid=&quot;B44-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;44&lt;/xref&gt;&lt;xref rid=&quot;B91-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;91&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  Anxiety index;  Risk assessment;   grooming behaviors in EPMT;   total number of line crossings of an open field after SPS;   SPS-induced decreasement in hypothalamic neuropeptide Y expression;   in locus cerulean tyrosine hydroxylase expression;   expression of BDNF&lt;xref rid=&quot;B44-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;44&lt;/xref&gt;&lt;xref rid=&quot;B91-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;91&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rb1, Re; ginsenoside Rh1, PPD&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;EPM test &lt;xref rid=&quot;B27-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;27&lt;/xref&gt;&lt;xref rid=&quot;B40-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;40&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Immobilization stress-induced ICR mice &lt;xref rid=&quot;B27-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;27&lt;/xref&gt;&lt;xref rid=&quot;B40-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;40&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  Time spent in open arms and open arm entries in EPM tests;   Immobilization stress-induced serum levels of corticosterone and IL-6;   anxiolytic effect via gamma-aminobutyrate A (GABA A) receptor(s)&lt;xref rid=&quot;B27-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;27&lt;/xref&gt;&lt;xref rid=&quot;B40-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;40&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rg3&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Two electrode voltage-clamp technique &lt;xref rid=&quot;B86-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;86&lt;/xref&gt;&lt;xref rid=&quot;B92-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;92&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Xenopus laevis frogs &lt;xref rid=&quot;B86-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;86&lt;/xref&gt;&lt;xref rid=&quot;B92-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;92&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  Anxiolytic effect via gamma-aminobutyrate A (GABA A) receptor(s)&lt;xref rid=&quot;B86-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;86&lt;/xref&gt;&lt;xref rid=&quot;B92-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;92&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Re&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;FST; EPM; AAT &lt;xref rid=&quot;B44-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;44&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Repeated immobilization stress-induced rats &lt;xref rid=&quot;B44-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;44&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  Stress-induced behavioral deficits in these behavioral tests;   TH expression in LC;   mRNA expression of BDNF in the hippocampus; modulate central noradrenergic system in rats&lt;xref rid=&quot;B44-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;44&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rg3 and ginsenoside Rh2&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;EPM test &lt;xref rid=&quot;B27-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;27&lt;/xref&gt;&lt;xref rid=&quot;B84-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;84&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Male ICR mice &lt;xref rid=&quot;B27-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;27&lt;/xref&gt;&lt;xref rid=&quot;B84-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;84&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  Time spent on the open arms and the number of open-arm entries; antagonize GABA/benzodiazepines&lt;xref rid=&quot;B27-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;27&lt;/xref&gt;&lt;xref rid=&quot;B84-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;84&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rb1, Rg1, and Ro&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;EPM test &lt;xref rid=&quot;B68-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;68&lt;/xref&gt;&lt;xref rid=&quot;B84-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;84&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Male ICR albino mice &lt;xref rid=&quot;B68-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;68&lt;/xref&gt;&lt;xref rid=&quot;B84-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;84&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  Both the frequency and duration of open arm entries&lt;xref rid=&quot;B68-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;68&lt;/xref&gt;&lt;xref rid=&quot;B84-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;84&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pseudoginsenoside-F11&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Light-dark box test; FST &lt;xref rid=&quot;B90-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;90&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MA-induced behavioral and neurochemical toxicities in mice &lt;xref rid=&quot;B90-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;90&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;  Anxiety-like behavior induced by methamphetamine (MA);   MA-induced prolonged latency;   the error counts;   contents of DOPAC, HVA, and 5-HIAA in the brain of MA-treated mice; antagonize decreases of DA&lt;xref rid=&quot;B90-molecules-23-00940&quot; ref-type=&quot;bibr&quot;&gt;90&lt;/xref&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>37173</offset><text>Name	Methods	Models	Neurobehavioral Effects and Mechanisms	 	PNS	OFT; SPT 	l-DOPA-induced mice; 5-HTP-induced rats 	  Basal [Ca2+]i levels;   immobility time;   levels of 5-HT, DA and NE.	 	Ginsenoside Rb1	EPM test 	SPS model and rat model of post-traumatic stress disorder 	  Anxiety index;  Risk assessment;   grooming behaviors in EPMT;   total number of line crossings of an open field after SPS;   SPS-induced decreasement in hypothalamic neuropeptide Y expression;   in locus cerulean tyrosine hydroxylase expression;   expression of BDNF.	 	Ginsenoside Rb1, Re; ginsenoside Rh1, PPD	EPM test 	Immobilization stress-induced ICR mice 	  Time spent in open arms and open arm entries in EPM tests;   Immobilization stress-induced serum levels of corticosterone and IL-6;   anxiolytic effect via gamma-aminobutyrate A (GABA A) receptor(s).	 	Ginsenoside Rg3	Two electrode voltage-clamp technique 	Xenopus laevis frogs 	  Anxiolytic effect via gamma-aminobutyrate A (GABA A) receptor(s).	 	Ginsenoside Re	FST; EPM; AAT 	Repeated immobilization stress-induced rats 	  Stress-induced behavioral deficits in these behavioral tests;   TH expression in LC;   mRNA expression of BDNF in the hippocampus; modulate central noradrenergic system in rats.	 	Ginsenoside Rg3 and ginsenoside Rh2	EPM test 	Male ICR mice 	  Time spent on the open arms and the number of open-arm entries; antagonize GABA/benzodiazepines.	 	Ginsenoside Rb1, Rg1, and Ro	EPM test 	Male ICR albino mice 	  Both the frequency and duration of open arm entries.	 	Pseudoginsenoside-F11	Light-dark box test; FST 	MA-induced behavioral and neurochemical toxicities in mice 	  Anxiety-like behavior induced by methamphetamine (MA);   MA-induced prolonged latency;   the error counts;   contents of DOPAC, HVA, and 5-HIAA in the brain of MA-treated mice; antagonize decreases of DA.	 	</text></passage><passage><infon key="file">molecules-23-00940-t002.xml</infon><infon key="id">molecules-23-00940-t002</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>39059</offset><text>EPM, elevated plus-maze.</text></passage><passage><infon key="file">molecules-23-00940-t003.xml</infon><infon key="id">molecules-23-00940-t003</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>39084</offset><text>Active ingredients of Panax notoginseng saponins.</text></passage><passage><infon key="file">molecules-23-00940-t003.xml</infon><infon key="id">molecules-23-00940-t003</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table xmlns:xlink=&quot;http://www.w3.org/1999/xlink&quot; frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;No.&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Name&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Structure&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PNS-1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rg1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;inline-graphic xlink:href=&quot;molecules-23-00940-i001.jpg&quot;/&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PNS-2&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rg3&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;inline-graphic xlink:href=&quot;molecules-23-00940-i002.jpg&quot;/&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PNS-3&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rg5 &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;inline-graphic xlink:href=&quot;molecules-23-00940-i003.jpg&quot;/&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PNS-4&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rb1 &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;inline-graphic xlink:href=&quot;molecules-23-00940-i004.jpg&quot;/&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PNS-5&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rb3&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;inline-graphic xlink:href=&quot;molecules-23-00940-i005.jpg&quot;/&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PNS-6&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Re&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;inline-graphic xlink:href=&quot;molecules-23-00940-i006.jpg&quot;/&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PNS-7&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rh1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;inline-graphic xlink:href=&quot;molecules-23-00940-i007.jpg&quot;/&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PNS-8&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Rh2 &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;inline-graphic xlink:href=&quot;molecules-23-00940-i008.jpg&quot;/&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PNS-9&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pseudoginsenoside-F11&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;inline-graphic xlink:href=&quot;molecules-23-00940-i009.jpg&quot;/&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PNS-10&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside Ro&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;inline-graphic xlink:href=&quot;molecules-23-00940-i010.jpg&quot;/&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PNS-11&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ginsenoside K&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;inline-graphic xlink:href=&quot;molecules-23-00940-i011.jpg&quot;/&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PNS-12&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Notoginsenoside R1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;inline-graphic xlink:href=&quot;molecules-23-00940-i012.jpg&quot;/&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>39134</offset><text>No.	Name	Structure	 	PNS-1	Ginsenoside Rg1		 	PNS-2	Ginsenoside Rg3		 	PNS-3	Ginsenoside Rg5 		 	PNS-4	Ginsenoside Rb1 		 	PNS-5	Ginsenoside Rb3		 	PNS-6	Ginsenoside Re		 	PNS-7	Ginsenoside Rh1		 	PNS-8	Ginsenoside Rh2 		 	PNS-9	Pseudoginsenoside-F11		 	PNS-10	Ginsenoside Ro		 	PNS-11	Ginsenoside K		 	PNS-12	Notoginsenoside R1		 	</text></passage><passage><infon key="file">molecules-23-00940-t004.xml</infon><infon key="id">molecules-23-00940-t004</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>39467</offset><text>Main predicted target information of Panax notoginseng (Burk) F. H. Chen.</text></passage><passage><infon key="file">molecules-23-00940-t004.xml</infon><infon key="id">molecules-23-00940-t004</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Node1&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Node2&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Node1 Accession&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Node2 Accession&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Score&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;APAF1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BAK1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000448165&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000353878&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.997&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;APAF1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BCL2&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000448165&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000329623&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.999&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;APAF1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BCL2A1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000448165&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000267953&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.912&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;APAF1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BIK&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000448165&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000216115&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.932&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;APAF1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;JUN&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000448165&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000360266&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.582&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;APAF1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MAPK8&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000448165&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000353483&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.611&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;APAF1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MCL1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000448165&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000358022&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.95&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;APAF1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NFKB1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000448165&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000226574&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.608&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;APAF1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TP53&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000448165&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000269305&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.996&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BAK1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;APAF1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000353878&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000448165&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.997&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BAK1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BBC3&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000353878&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000404503&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.414&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BAK1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BCL2&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000353878&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000329623&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.999&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BAK1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BCL2A1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000353878&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000267953&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.987&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BAK1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BIK&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000353878&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000216115&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.583&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BAK1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;JUN&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000353878&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000360266&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.852&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BAK1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;JUNB&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000353878&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000303315&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.658&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BAK1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;JUND&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000353878&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000252818&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.671&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BAK1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MAPK8&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000353878&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000353483&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.83&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BAK1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MCL1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000353878&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENSP00000358022&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.99&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>39541</offset><text>Node1	Node2	Node1 Accession	Node2 Accession	Score	 	APAF1	BAK1	ENSP00000448165	ENSP00000353878	0.997	 	APAF1	BCL2	ENSP00000448165	ENSP00000329623	0.999	 	APAF1	BCL2A1	ENSP00000448165	ENSP00000267953	0.912	 	APAF1	BIK	ENSP00000448165	ENSP00000216115	0.932	 	APAF1	JUN	ENSP00000448165	ENSP00000360266	0.582	 	APAF1	MAPK8	ENSP00000448165	ENSP00000353483	0.611	 	APAF1	MCL1	ENSP00000448165	ENSP00000358022	0.95	 	APAF1	NFKB1	ENSP00000448165	ENSP00000226574	0.608	 	APAF1	TP53	ENSP00000448165	ENSP00000269305	0.996	 	BAK1	APAF1	ENSP00000353878	ENSP00000448165	0.997	 	BAK1	BBC3	ENSP00000353878	ENSP00000404503	0.414	 	BAK1	BCL2	ENSP00000353878	ENSP00000329623	0.999	 	BAK1	BCL2A1	ENSP00000353878	ENSP00000267953	0.987	 	BAK1	BIK	ENSP00000353878	ENSP00000216115	0.583	 	BAK1	JUN	ENSP00000353878	ENSP00000360266	0.852	 	BAK1	JUNB	ENSP00000353878	ENSP00000303315	0.658	 	BAK1	JUND	ENSP00000353878	ENSP00000252818	0.671	 	BAK1	MAPK8	ENSP00000353878	ENSP00000353483	0.83	 	BAK1	MCL1	ENSP00000353878	ENSP00000358022	0.99	 	</text></passage></document>
</collection>